<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Neurobiol</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Neurobiol</journal-id><journal-title-group><journal-title>Molecular Neurobiology</journal-title></journal-title-group><issn pub-type="ppub">0893-7648</issn><issn pub-type="epub">1559-1182</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6476862</article-id><article-id pub-id-type="publisher-id">1298</article-id><article-id pub-id-type="doi">10.1007/s12035-018-1298-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer&#8217;s Disease</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>V&#233;lez</surname><given-names>Jorge I.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lopera</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Creagh</surname><given-names>Penelope K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pi&#241;eros</surname><given-names>Laura B.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Das</surname><given-names>Debjani</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Cervantes-Henr&#237;quez</surname><given-names>Martha L.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Acosta-L&#243;pez</surname><given-names>Johan E.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Isaza-Ruget</surname><given-names>Mario A.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Espinosa</surname><given-names>Lady G.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Easteal</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Quintero</surname><given-names>Gustavo A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Claudia Tamar</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mastronardi</surname><given-names>Claudio A.</given-names></name><address><email>claudio.mastronardi@urosario.edu.co</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8529-0574</contrib-id><name><surname>Arcos-Burgos</surname><given-names>Mauricio</given-names></name><address><email>oscarma.arcos@urosario.edu.co</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2180 7477</institution-id><institution-id institution-id-type="GRID">grid.1001.0</institution-id><institution>Genomics and Predictive Medicine Group, Department of Genome Sciences, John Curtin School of Medical Research, </institution><institution>The Australian National University, </institution></institution-wrap>Canberra, ACT 2600 Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0486 8632</institution-id><institution-id institution-id-type="GRID">grid.412188.6</institution-id><institution>Universidad del Norte, </institution></institution-wrap>Barranquilla, Colombia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8882 5269</institution-id><institution-id institution-id-type="GRID">grid.412881.6</institution-id><institution>Neuroscience Research Group, </institution><institution>University of Antioquia, </institution></institution-wrap>Medell&#237;n, Colombia </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2205 5940</institution-id><institution-id institution-id-type="GRID">grid.412191.e</institution-id><institution>GENIUROS, Center for Research in Genetics and Genomics, Institute of Translational Medicine, School of Medicine and Health Sciences, </institution><institution>Universidad del Rosario, </institution></institution-wrap>Bogot&#225;, Colombia </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2180 7477</institution-id><institution-id institution-id-type="GRID">grid.1001.0</institution-id><institution>Genome Diversity and Health Group, Department of Genome Sciences, John Curtin School of Medical Research, </institution><institution>The Australian National University, </institution></institution-wrap>ACT, Canberra, 2600 Australia </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.441873.d</institution-id><institution>Grupo de Neurociencias del Caribe, </institution><institution>Universidad Sim&#243;n Bol&#237;var, </institution></institution-wrap>Barranquilla, Colombia </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.442116.4</institution-id><institution>INPAC Research Group, </institution><institution>Fundaci&#243;n Universitaria Sanitas, </institution></institution-wrap>Bogot&#225;, Colombia </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2205 5940</institution-id><institution-id institution-id-type="GRID">grid.412191.e</institution-id><institution>Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, </institution><institution>Universidad del Rosario, </institution></institution-wrap>Bogot&#225;, Colombia </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2205 5940</institution-id><institution-id institution-id-type="GRID">grid.412191.e</institution-id><institution>Neuroscience Group (NeUROS), Institute of Translational Medicine, School of Medicine and Health Sciences, </institution><institution>Universidad del Rosario, </institution></institution-wrap>Bogot&#225;, Colombia </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="ppub"><year>2019</year></pub-date><volume>56</volume><issue>5</issue><fpage>3235</fpage><lpage>3243</lpage><history><date date-type="received"><day>28</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>2</day><month>8</month><year>2018</year></date></history><permissions><copyright-statement>&#169; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The identification of novel genetic variants contributing to the widespread in the age of onset (AOO) of Alzheimer&#8217;s disease (AD) could aid in the prognosis and/or development of new therapeutic strategies focused on early interventions. We recruited 78 individuals with AD from the Paisa genetic isolate in Antioquia, Colombia. These individuals belong to the world largest multigenerational and extended pedigree segregating AD as a consequence of a dominant fully penetrant mutation in the <italic>PSEN1</italic> gene and exhibit an AOO ranging from the early 1930s to the late 1970s. To shed light on the genetic underpinning that could explain the large spread of the age of onset (AOO) of AD, 64 single nucleotide polymorphisms (SNP) associated with neuroanatomical, cardiovascular, and cognitive measures in AD were genotyped. Standard quality control and filtering procedures were applied, and single- and multi-locus linear mixed-effects models were used to identify AOO-associated SNPs. A full two-locus interaction model was fitted to define how identified SNPs interact to modulate AOO. We identified two key epistatic interactions between the <italic>APOE*E2</italic> allele and SNPs <italic>ASTN2</italic>-rs7852878 and <italic>SNTG1</italic>-rs16914781 that delay AOO by up to ~&#8201;8&#160;years (95% CI 3.2&#8211;12.7, <italic>P</italic>&#8201;=&#8201;1.83&#8201;&#215;&#8201;10<sup>&#8722;3</sup>) and ~&#8201;7.6&#160;years (95% CI 3.3&#8211;11.8, <italic>P</italic>&#8201;=&#8201;8.69&#8201;&#215;&#8201;10<sup>&#8722;4</sup>), respectively, and validated our previous finding indicating that <italic>APOE*E2</italic> delays AOO of AD in <italic>PSEN1</italic> E280 mutation carriers. This new evidence involving <italic>APOE*E2</italic> as an AOO delayer could be used for developing precision medicine approaches and predictive genomics models to potentially determine AOO in individuals genetically predisposed to AD.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1007/s12035-018-1298-z) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Alzheimer&#8217;s disease</kwd><kwd><italic>APOE*E2</italic></kwd><kwd>Age of onset</kwd><kwd><italic>ASTN2</italic></kwd><kwd>Genetic isolate</kwd><kwd><italic>PSEN1</italic></kwd><kwd>Extreme phenotypes</kwd><kwd><italic>SNTG1</italic></kwd></kwd-group><funding-group><award-group><funding-source><institution>COLCIENCIAS</institution></funding-source><award-id>1115-408-20543</award-id><principal-award-recipient><name><surname>Lopera</surname><given-names>Francisco</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>FOFICO</institution></funding-source><award-id>32101 PE0031</award-id><principal-award-recipient><name><surname>V&#233;lez</surname><given-names>Jorge I.</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000995</institution-id><institution>Australian National University</institution></institution-wrap></funding-source><award-id>R42100-2</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">The prevalence of Alzheimer&#8217;s disease (AD) continues growing at an alarming pace. In 2006, the number of patients with AD was reported to be over 26.6 million worldwide, and it could rise by approximately fourfold to over 106.2 million by 2050 [<xref ref-type="bibr" rid="CR1">1</xref>]. This neurodegenerative condition is incurable and constitutes a massive burden for patients, their families, and the public health system.</p><p id="Par3">Genetic isolates have shown to be a powerful tool for the genetic mapping of inherited diseases [<xref ref-type="bibr" rid="CR2">2</xref>]. For more than three decades, we have been studying the world&#8217;s largest known pedigree segregating AD in which the E280A (p.Glu280Ala) mutation in the <italic>Presenilin-1</italic> (<italic>PSEN1</italic>) gene causes early-onset AD [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. This pedigree is genetically homogeneous, exhibits a high degree of endogamy, and originated centuries ago as a consequence of a founder effect during the colonizing of Colombia by Spaniards [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>]. To date, more than 5000 individuals descend from the original founder, 1784 have been enrolled in a comprehensive ongoing clinical monitoring study, and 1181 individuals have been genotyped (459 carry the <italic>PSEN1</italic> E280A mutation) [<xref ref-type="bibr" rid="CR3">3</xref>]. Although the median Alzheimer&#8217;s disease age of onset (ADAOO) in this mentioned pedigree is ~&#8201;49&#160;years [<xref ref-type="bibr" rid="CR3">3</xref>], it varies from the early 30s to the late 70s in some individuals [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR10">10</xref>]. It is hypothesized that this substantial variation in the ADAOO is the result of interactions between <italic>PSEN1</italic> and other key genes to modify ADAOO, and that this modification results in some members of this pedigree developing signs and symptoms of AD at an earlier or later age than other members (that is, these gene interactions with <italic>PSEN1</italic> either accelerate or decelerate ADAOO).</p><p id="Par4">In a recent study, we performed a pooling/resampling-based genome-wide association study (GWAS) and successfully identified both known and novel loci associated with ADAOO in individuals with the E280A mutation, including <italic>DAOA</italic>, <italic>NPHP1</italic>, <italic>CLUAP1</italic>, <italic>EXOC2</italic>, <italic>CADPS2</italic>, <italic>GREM2</italic>, and <italic>CD44</italic> [<xref ref-type="bibr" rid="CR7">7</xref>]. Subsequent genetic studies in <italic>PSEN1</italic> E280A mutation carriers identified functional exonic variants within some of these genes [<xref ref-type="bibr" rid="CR9">9</xref>] and demonstrated that the <italic>APOE*E2</italic> allele (rs7412, <italic>P</italic>&#8201;=&#8201;5.44&#8201;&#215;&#8201;10<sup>&#8722;35</sup>, <italic>P</italic><sub>FDR</sub>&#8201;=&#8201;2.13&#8201;&#215;&#8201;10<sup>&#8722;30</sup>) delays ADAOO by ~&#8201;12&#160;years [<xref ref-type="bibr" rid="CR8">8</xref>]. Interestingly, in a separate study, we also reported an exonic missense mutation in the <italic>DAOA</italic> gene (rs2391191, <italic>P</italic>&#8201;=&#8201;1.94&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) that was found to delay the ADAOO in patients from the Paisa cohort in ~&#8201;4&#160;years [<xref ref-type="bibr" rid="CR9">9</xref>]. It is also noteworthy to remark that the variant <italic>SH3RF3-</italic>rs6542814, flanking <italic>NPHP1</italic>, delays ADAOO by ~&#8201;9&#160;years [<xref ref-type="bibr" rid="CR11">11</xref>], and the presence of two copies of the rare allele in <italic>NPHP1-</italic>rs906815 (rs906815, <italic>P</italic>&#8201;=&#8201;4.51&#8201;&#215;&#8201;10<sup>&#8722;6</sup>) accelerates ADAOO by ~&#8201;21&#160;years compared to the common allele in Caribbean Hispanic families carrying the <italic>PSEN1</italic> G206A mutation [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par5">Since cognitive function and decline are highly polygenic traits where a large number of genetic factors of small effect are involved, it is difficult to find associations between these factors and clinical outcomes assessing cognition or cognitive decline [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. One of the standard methods to overcome this issue is to increase the sample size and subsequently increase the power to detect small effect sizes. Another possible approach is to perform targeted analysis by employing specific genetic markers that could be relevant to AD.</p><p id="Par6">In the present study, we screened 78 individuals from the above-described pedigree and genotyped 65 single nucleotide polymorphisms (SNPs) previously reported to be associated with dementia and cognition. These SNPs showed association with neuroanatomical differences in brain areas that play essential roles in cognition such as the hippocampus, or that were related with hypertension because common genetic links appear to occur between AD and cardiovascular disease (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>). We successfully replicated the association between the <italic>APOE*E2</italic> allele and ADAOO, found two novel variants that also delay the age of onset of this pathological condition, and identified epistatic interactions between the <italic>APOE*E2</italic> allele and variants within the <italic>Astrotactin 2</italic> (<italic>ASTN2</italic>) and <italic>Syntrophin</italic>, <italic>Gamma 1</italic> (<italic>SNTG1</italic>) genes that dramatically delay the ADAOO in <italic>PSEN1</italic> E280A mutation carriers.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Subjects</title><p id="Par7">Seventy-eight individuals with AD (47 [60%] women, 31 men [40%]) carrying the <italic>PSEN1</italic> E280A mutation from the Metropolitan Area of Medellin in Antioquia, Colombia, were included in this study. Genetic studies have shown that this community has not been subject to microdifferentiation [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Clinical, neurological, and neuropsychological assessments at the Group of Neurosciences AD Clinic used a Spanish version of The Consortium to Establish a Registry for Alzheimer&#8217;s Disease (CERAD) evaluation battery [<xref ref-type="bibr" rid="CR15">15</xref>] adapted for the cultural and linguistic characteristics specific to this population [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>]. Mild cognitive impairment (MCI) and AD affection status were defined based on Petersen&#8217;s and DSM-IV criteria, respectively [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The Ethics Committee of the University of Antioquia approved this study (Protocol 1115-408-20543). Informed consent was obtained from all participants.</p></sec><sec id="Sec4"><title>DNA Extraction and SNP Genotyping</title><p id="Par8">Genomic DNA was extracted from peripheral blood, and whole-genome amplified, fragmented, hybridized, fluorescently tagged, and scanned using the Infinium assay [<xref ref-type="bibr" rid="CR21">21</xref>]. Sixty-four SNPs were selected based on previous associations with dementia, cognition, neuroanatomical differences, and blood pressure (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>), and further selected in our sample. Genomic DNA was normalized to a concentration of ~&#8201;50&#160;ng/&#956;l, and 2.5&#160;&#956;L of genomic DNA was mixed with 2.5&#160;&#956;L TaqMan OpenArray Master Mix. The resulting samples were dispensed using the OpenArray&#174; AccuFill&#8482; System onto OpenArray plates with each plate containing 48 samples and 65 SNP assays per sample. The QuantStudio&#8482; 12K Flex instrument (Applied Biosystems, Carlsbad, CA, USA) was used to perform the real-time PCR reactions on the loaded OpenArray plates. The fluorescence emission results were read using the OpenArray&#174; SNP Genotyping Analysis software v1 (Applied Biosystems), and the genotyping analysis performed using TaqMan&#174; Genotyper v1.3 with the auto call feature and the default settings.</p></sec><sec id="Sec5"><title>Genetic Association Analysis</title><p id="Par9">Genotypes for the selected SNPs were processed, subject to quality control and association analysis performed using Golden Helix&#174; SNP Variation Suite (SVS) 8.3.2 (Golden Helix, Inc. Bozeman, MT, USA). Quality control exclusion criteria included (i) deviations from Hardy-Weinberg equilibrium with <italic>P</italic>&#8201;&lt;&#8201;0.05/<italic>m</italic> (where <italic>m</italic> is the number of markers included for analysis), (ii) a minimum genotype call rate of 90%, (iii) the presence of one or more than two alleles, and (iv) a minor allele frequency (MAF)&#8201;&lt;&#8201;1% to exclude rare variants [<xref ref-type="bibr" rid="CR22">22</xref>]. Genotype and allelic frequencies were estimated by maximum likelihood, and the identity by descent (IBD) matrix between all pairs of individuals was used for quality control.</p><p id="Par10">Single- and multi-locus additive, dominant and recessive linear mixed-effect models (LMEMs) with up to 10 steps in the backward/forward optimization algorithm [<xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>] were used to study the association between ADAOO and the aforementioned SNPs. The advantage of these models is the inclusion of both fixed (sex and years of education) and random effects, the latter to account for potential inbreeding (which, in our case, was estimated using the IBD matrix described above). A single-locus LMEM assumes that all loci have a small effect on the trait, while a multi-locus LMEM assumes that several loci have a large effect on the trait [<xref ref-type="bibr" rid="CR25">25</xref>]. The optimal model was selected using a comprehensive exploration of multiple criteria (see [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR10">10</xref>] for more information). After the estimation procedure completed, the <italic>P</italic> values associated with the LMEM coefficients <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\widehat{\beta}}_1,{\widehat{\beta}}_2,\dots, {\widehat{\beta}}_{\mathrm{m}} $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:msub><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>&#8230;</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mi mathvariant="normal">m</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12035_2018_1298_Article_IEq1.gif"/></alternatives></inline-formula> were extracted and corrected for multiple testing using the false discovery rate (FDR) [<xref ref-type="bibr" rid="CR26">26</xref>] and a method based on extreme-values theory [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec6"><title>Effect of SNP&#160;&#215;&#160;SNP Interactions on ADAOO</title><p id="Par11">We evaluated potential SNP&#160;&#215;&#160;SNP interactions between markers modifying ADAOO in carriers of the E280A mutation using a modified version of the full two-locus epistatic model [<xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>]. Conceptually, the analysis of SNP&#160;<bold>&#215;</bold>&#160;SNP interactions intends to determine whether the joint effect of two SNPs on the ADAOO is greater than that of either marker alone. For each pair of markers found to modify ADAOO in our patients, the ADAOO was compared at each genotype combination after correcting for potential confounding variables. Since the maximum number of genotype combinations is nine, it is likely that the sample size at each of these combinations is small. To overcome this, a nonparametric bootstrap [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] procedure with <italic>B</italic>&#8201;=&#8201;10,000 replicates was implemented to derive permutation-based <italic>P</italic> values for these comparisons.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>ADAOO Distribution</title><p id="Par12">The average ADAOO in all <italic>PSEN1</italic> E280A mutation carriers was 48.8&#160;&#177;&#160;4.9&#160;years (blue vertical&#160;line, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>a). Mean ADAOO did not differ significantly by gender (<italic>P</italic>&#8201;=&#8201;0.55, Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). A total of 37 patients (20 women [54%] and 17 men [46%]) had an ADAOO &lt;&#8201;48&#160;years [<xref ref-type="bibr" rid="CR7">7</xref>]. Years of education ranged between 0 and 16&#160;years; four patients (5%) never attended school, 43 (55%) finished elementary school (grades 1 to 5), 26 (34%) finished high school (grades 6 to 11, inclusive), and 5 (6%) had tertiary education. The average ADAOO differed across education groups (<italic>F</italic><sub>3,74</sub>&#8201;=&#8201;3.724, <italic>P</italic>&#8201;=&#8201;0.015) (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>b). However, closer inspection of the data revealed that this effect was a consequence of the <italic>APOE*E2</italic> allele in a 66-year-old male who never attended school. After excluding individuals that did not attend school, the effect of education groups on the ADAOO was no longer statistically significant (<italic>F</italic><sub>2,71</sub>&#8201;=&#8201;0.373, <italic>P</italic>&#8201;=&#8201;0.690). Thirty-seven (47%) individuals developed AD earlier than the average for this population (ADAOO &lt;&#8201;48&#160;years; early onset) and 41 developed late-onset AD (ADAOO &#8805;&#8201;48&#160;years). The average ADAOO was statistically different between these groups (early onset 44.8&#160;&#177;&#160;1.9, late onset 52.5&#160;&#177;&#160;3.9, <italic>P</italic>&#8201;&lt;&#8201;2.5&#8201;&#215;&#8201;10<sup>&#8722;16</sup>, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>b). No association between gender (<italic>P</italic>&#8201;=&#8201;0.979, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>b) or years of education was found (<italic>R</italic><sup>2</sup>&#8201;=&#8201;0.028, <italic>P</italic>&#8201;=&#8201;0.076, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>b).<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> ADAOO distribution in 78 patients with Alzheimer&#8217;s disease carrying the <italic>PSEN1</italic> E280A mutation. Notice the presence of two hidden groups with an average ADAOO of ~&#8201;46 and ~&#8201;51&#160;years old, respectively. To identify these groups, a mixture of two Gaussian distributions was fitted as implemented in the mixtools [<xref ref-type="bibr" rid="CR33">33</xref>] package for R [<xref ref-type="bibr" rid="CR34">34</xref>]; the number of hidden groups was determined based on the log-likelihood criterion (the lowest the better). The blue vertical line is at ~&#8201;48&#160;years, which corresponds to the average ADAOO in our sample. Box and violin plots for the ADAOO by <bold>b</bold> gender, <bold>c</bold> early onset, and <bold>d</bold> education group. Only differences in the average ADAOO were found by AD status. <bold>e</bold> ADAOO as a function of the years of education. <italic>AD</italic> Alzheimer&#8217;s disease, <italic>ADAOO</italic> Alzheimer&#8217;s disease age of onset</p></caption><graphic xlink:href="12035_2018_1298_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec9"><title>ADAOO-Associated SNPs</title><p id="Par13">A dominant multi-locus LMEM with three steps in the forward/backward selection algorithm [<xref ref-type="bibr" rid="CR25">25</xref>] was selected based on the <italic>mPPA</italic> and pseudo-heritability criteria. This oligogenic model includes variants rs7412 (<italic>APOE</italic>, <italic>P</italic>&#8201;=&#8201;1.94&#8201;&#215;&#8201;10<sup>&#8722;4</sup>, <italic>P</italic><sub>FDR</sub>&#8201;=&#8201;9.34&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, Table <xref rid="Tab1" ref-type="table">1</xref>), rs7852878 (<italic>ASTN2</italic>, <italic>P</italic>&#8201;=&#8201;1.94&#8201;&#215;&#8201;10<sup>&#8722;4</sup>, <italic>P</italic><sub>FDR</sub>&#8201;=&#8201;9.34&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, Table <xref rid="Tab1" ref-type="table">1</xref>), and rs16914781 (<italic>SNTG1</italic>, <italic>P</italic>&#8201;=&#8201;1.94&#8201;&#215;&#8201;10<sup>&#8722;4</sup>, <italic>P</italic><sub>FDR</sub>&#8201;=&#8201;9.34&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, Table <xref rid="Tab1" ref-type="table">1</xref>), which explains ~&#8201;43% of the ADAOO variance. The proportion of the ADAOO variance explained by each marker is ~&#8201;24, ~&#8201;13, and ~&#8201;8% for rs7412, rs7852872, and rs16914781, respectively. No gender- or education-specific effect of these SNPs was found (Table <xref rid="Tab1" ref-type="table">1</xref>). Because all estimated <italic>&#946;</italic> coefficients from this model are positive (Table <xref rid="Tab1" ref-type="table">1</xref>), these alleles delay the ADAOO in our sample of <italic>PSEN1</italic> E280A mutation carriers. In particular, individuals with the C/T genotype in <italic>APOE</italic>-rs7412 (that is, the <italic>APOE*E2</italic> allele) have an ADAOO ~&#8201;8&#160;years later than that of individuals with the C/C genotype (<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \widehat{\beta}=8.21,{\widehat{\mathrm{SE}}}_{\widehat{\beta}} $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>8.21</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>SE</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover></mml:msub><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12035_2018_1298_Article_IEq2.gif"/></alternatives></inline-formula>=&#8201;1.5; Table <xref rid="Tab1" ref-type="table">1a</xref> and Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>a). Likewise, <italic>PSEN1</italic> E280A mutation carriers with C/G or G/G in <italic>ASTN2</italic>-rs7852878 have an ADAOO ~&#8201;3.7&#160;years later compared to that of C/C individuals (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \widehat{\beta} = 3.68,{\widehat{\mathrm{SE}}}_{\widehat{\beta}} $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:mover accent="true"><mml:mrow><mml:mi>&#946;</mml:mi><mml:mspace width="0.25em"/></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>3.68</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>SE</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover></mml:msub><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12035_2018_1298_Article_IEq3.gif"/></alternatives></inline-formula>=&#8201;0.88; Table <xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>a). In addition, members of this pedigree with the G/G genotype in <italic>SNTG1</italic>-rs16914781 have a ~&#8201;3.3&#160;years delay in the ADAOO compared to those with A/A or A/G (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \widehat{\beta}=3.27,{\widehat{\mathrm{SE}}}_{\widehat{\beta}} $$\end{document}</tex-math><mml:math id="M8" display="inline"><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>3.27</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>SE</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mover accent="true"><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover></mml:msub><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12035_2018_1298_Article_IEq4.gif"/></alternatives></inline-formula>=&#8201;0.872; Table <xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>a).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Results of the association analysis for ADAOO in 78 patients with <italic>PSEN1</italic> E280A Alzheimer&#8217;s disease (a). Proportion of variance explained and gender- and education-specific effects of ADAOO associated SNPs (b)</p></caption><table-wrap-foot><p><sup>a</sup>UCSC GRCh37/hg19 coordinates</p><p><italic>ADAOO</italic> Alzheimer&#8217;s disease age of onset, <italic>Chr</italic> chromosome, <italic>SNP</italic> single nucleotide polymorphism, <italic>Ref/Alt</italic> reference/alternate allele, <italic>MA</italic> minor allele, <italic>Freq</italic> frequency, <italic>CR</italic> call rate, <italic>&#946;</italic> regression coefficient, <italic>SE</italic><sub><italic>&#946;</italic></sub> standard error of <italic>&#946;</italic>, <italic>P P</italic> value, <italic>FDR</italic> false discovery rate, <italic>PVE</italic> proportion of variance explained, <italic>&#967;</italic><sup>2</sup> test statistic, <italic>df</italic> degrees of freedom</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p><bold>a</bold> Effect of the presence of the <italic>APOE*E2</italic> allele, and the genotypes in rs7852872-<italic>ASTN2</italic> and rs16914781-<italic>SNTG1</italic> on ADAOO. A two-sample <italic>t</italic> test indicates the presence of the <italic>APOE*E2</italic> allele increases the ADAOO by ~&#8201;8.1&#160;years (<italic>t</italic><sub>72</sub>&#8201;=&#8201;4.67, 95% CI 4.6&#8211;11.6, <italic>P</italic>&#8201;=&#8201;1.37&#8201;&#215;&#8201;10<sup>&#8722;6</sup>). Pink, blue, and dotted horizontal lines are, respectively, the within genotype average ADAOO, the individuals&#8217; ADAOO, and the global average ADAOO in our sample. <bold>b</bold> Effect of the <italic>APOE</italic>*<italic>E2</italic>&#215;<italic>ASTN2</italic> and <italic>APOE</italic>*<italic>E2</italic>&#215;<italic>SNTG1</italic> interactions on ADAOO. Green lines symbolize protection, red lines susceptibility, and the gray line the average ADAOO in our sample. Note that the <italic>APOE*E2</italic> allele delays ADAOO regardless of the interacting marker. Abbreviations as in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref></p></caption><graphic xlink:href="12035_2018_1298_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec10"><title>Effect of the <italic>APOE</italic>*<italic>E2</italic>&#215;<italic>ASTN2</italic> and <italic>APOE</italic>*<italic>E2</italic>&#215;<italic>SNTG1</italic> Interactions on ADAOO</title><p id="Par14">The presence of the <italic>APOE*E2</italic> allele in E280A mutation carriers was found to delay ADAOO by ~&#8201;8.1&#160;years (95% CI 4.65&#8211;11.58, <italic>P</italic>&#8201;=&#8201;1.37&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b). A similar effect was observed when this same allele interacts with markers <italic>ASTN2</italic>-rs7852878 and <italic>SNTG1</italic>-rs16914781, which suggests an epistatic mechanism between <italic>APOE*E2</italic> and <italic>ASTN2</italic> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b), and between <italic>APOE*E2</italic> and <italic>SNTG1</italic> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b) to modify the ADAOO in carriers of the E280A mutation. In particular, the ADAOO in individuals with the <italic>APOE*E2</italic> allele and C/G genotype in <italic>ASTN2</italic>-rs7852878 is ~&#8201;8&#160;years (95% CI 3.2&#8211;12.7, <italic>P</italic>&#8201;=&#8201;1.83&#8201;&#215;&#8201;10<sup>&#8722;3</sup>) later than that of individuals lacking the <italic>APOE*E2</italic> allele (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b). Similarly, those with C/C in <italic>ASTN2</italic>-rs7852878 carrying the <italic>APOE*E2</italic> allele have an ADAOO ~&#8201;6.6&#160;years (9% CI 1.2&#8211;11.9, <italic>P</italic>&#8201;=&#8201;0.017) later compared to non-carriers (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b). Conversely, individuals with the A/A genotype in <italic>SNTG1</italic>-rs16914781 carrying the <italic>APOE*E2</italic> allele have an ADAOO ~&#8201;7.6&#160;years (95% CI 3.3&#8211;11.8, <italic>P</italic>&#8201;=&#8201;8.69&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) later than that observed in non-carriers (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b), and the presence of the <italic>APOE*E2</italic> allele delayed the ADAOO in ~&#8201;11&#160;years (95% CI 6.6&#8211;15.2, <italic>P</italic>&#8201;=&#8201;1.7&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) in individuals with the A/G genotype in <italic>SNTG1</italic>-rs16914781 (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>b). We found no effect of the <italic>ASTN2</italic>&#215;<italic>SNTG1</italic> interaction on the ADAOO.</p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par15">In this study, we targeted neuroanatomical, cardiovascular, and cognitive-associated markers in familial AD from the Paisa community, a genetic isolate from Antioquia, Colombia. Even though several GWAS studies have provided a potential list of a handful of putative candidate genes for sporadic AD (i.e., an age of onset &gt;&#8201;65&#160;years), most of those genes failed in their replication. It is well known that heterogeneity of genetic and environmental background could largely account for this apparent discrepancy. Thus, to increase power in our analyses, our approach was aimed at performing a targeted analysis in a multigenerational family from a local community that is exposed to a quite homogenous environment. More specifically, we employed 65 genetic markers related to Alzheimer&#8217;s disease in a large family from the local Paisa community that originated from a common ancestor from Northern Spain during the 1500s. In this community, Alzheimer&#8217;s disease is quite common as a result of the high frequency of the autosomal dominant and fully penetrant <italic>PSEN1</italic> E280A allele. Our main goal was to shed light on the genetic underpinning that could explain the large spread of the age of onset of AD that ranks from the early 1930s to late 1970s.</p><p id="Par16">This cohort was also subjected to two earlier preliminary studies in which smaller sample sizes were employed, and different outcomes were observed [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Since the time those studies were performed, more E280A carriers have been identified. Hence, here we expanded the sample to detect new genes that could explain the widespread of the ADAOO observed in E280A carriers. Our present data show that the presence of the <italic>APOE*E2</italic> allele confers protection by delaying the ADAOO by ~&#8201;8.2&#160;years (95% CI 5.2&#8211;11.2, <italic>P</italic>&#160;=&#8201;4.21&#8201;&#215;&#8201;10<sup>&#8722;5</sup>; Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>a), which confirms our most recent reported finding in a sample of 71 <italic>PSEN1</italic> E280A mutation carriers displaying an extreme ADAOO [<xref ref-type="bibr" rid="CR8">8</xref>]. Basically, by increasing the sample size to 78 patients carrying the E280A mutation, in the present study, we corroborated the decelerating <italic>APOE*E2</italic> effect on ADAOO previously shown in individuals from the Paisa community [<xref ref-type="bibr" rid="CR8">8</xref>]. Power analyses indicate that, overall, the ADAOO can be safely tested using our current sample size (see <xref rid="MOESM1" ref-type="media">Supplementary Material</xref>).</p><p id="Par17">Collectively, previous and current work in this genetic isolate suggests that the ADAOO accelerating and decelerating effects conferred by the <italic>APOE</italic>*<italic>E4</italic> and <italic>APOE</italic>*<italic>E2</italic> alleles, respectively, become evident. Therefore, our results provide convincing evidence that not only does the <italic>APOE*E2</italic> allele exert a protective role in the onset of AD in sporadic patients [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], but also in the <italic>PSEN1</italic> E280A familial cases.</p><p id="Par18">The role of beta-amyloid (A&#946;) in AD has been openly challenged [<xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>]. One of the primary reasons is that there is evidence showing that A&#946; deposition rises with healthy aging and its increase is not necessarily correlated with the onset of dementia and the progression to AD [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. However, it is noteworthy to remark that patients with familial Alzheimer&#8217;s disease display fibrillar A&#946; pathology several years before symptoms onset [<xref ref-type="bibr" rid="CR43">43</xref>]. For instance, by employing florbetapir PET analyses, Fleisher et al. showed that individuals from the Antioquia cohort carrying the <italic>PSEN1</italic> E280A mutation showed evident accumulation of fibrillar A&#946; at a mean age of 28.2&#160;years, which was approximately 16 and 21&#160;years before the expected MCI and dementia onset, respectively [<xref ref-type="bibr" rid="CR44">44</xref>]. Thus, it appears that fibrillar A&#946; pathology could represent an early preclinical stage of AD. Another piece of evidence supporting that A&#946; is involved in the pathogenesis of AD is the fact that the three well-known genes that cause a dominant Mendelian form of familial AD (<italic>APP</italic>, <italic>PSEN1</italic>, and <italic>PSEN2</italic>) are involved in the processing of A&#946; peptides [<xref ref-type="bibr" rid="CR45">45</xref>&#8211;<xref ref-type="bibr" rid="CR47">47</xref>]. A&#946; peptides vary between 37 and 43 amino acids in length depending on the &#947;-secretase cleavage site. Mounting evidence suggests that the majority of early-onset familial AD mutations in <italic>APP</italic>, <italic>PSEN1</italic>, and <italic>PSEN2</italic> elevate the A&#946;1&#8211;42:A&#946;1&#8211;40 ratio, which favors the aggregation of neurotoxic oligomeric assemblies of A&#946;. It is considered that A&#946;1&#8211;42 is more amyloidogenic than other A&#946; peptides, which assemble into soluble A&#946; oligomers that are thought to cause synaptic loss and a progressive cognitive decline in AD [<xref ref-type="bibr" rid="CR48">48</xref>]. A&#946;1&#8211;42 oligomers can elicit an inflammatory cascade by triggering the activation of microglia [<xref ref-type="bibr" rid="CR49">49</xref>]. Moreover, A&#946; oligomers associate with membrane proteins in synapses [<xref ref-type="bibr" rid="CR50">50</xref>] and astrocytes [<xref ref-type="bibr" rid="CR51">51</xref>]. In post-synaptic, neurons increase the Ca<sup>2+</sup> concentration causing inflammation and cell death [<xref ref-type="bibr" rid="CR50">50</xref>]. Post-mortem studies carried in brain tissue from the E280A kindred suggest that their <italic>PSEN1</italic> mutation selectively increases the processing of the amyloidogenic peptide A&#946;1&#8211;42 [<xref ref-type="bibr" rid="CR47">47</xref>]. Mounting evidence suggests that there are links between A&#946; and tau in the pathogenesis of AD [<xref ref-type="bibr" rid="CR52">52</xref>&#8211;<xref ref-type="bibr" rid="CR54">54</xref>]. A&#946; promotes abnormal tau phosphorylation and aggregation into neurofibrillary tangles, which is associated with neuronal toxicity and impaired cognition in AD. For instance, in functional studies employing transgenic animal models and neuronal cell culture, it was found that a 56-kDa amyloid oligomer elicited an influx in intracellular Ca2+ that triggered phosphorylation of tau at a site that promoted its aggregation [<xref ref-type="bibr" rid="CR55">55</xref>]. This recent finding expands previous evidence supporting a possible link between A&#946; and tau in the pathogenesis of AD [<xref ref-type="bibr" rid="CR52">52</xref>&#8211;<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par19">In this context, it can be argued that the <italic>APOE*E2</italic> variant might cause a beneficial impact on AD by improving the clearance of central A&#946;, and consequently delay the onset of AD [<xref ref-type="bibr" rid="CR56">56</xref>]. On the other hand, the <italic>APOE*E4</italic> variant accelerates the ADAOO since it performs poorly in the clearance of A&#946; peptides thereby favoring the formation of aggregates and the occurrence of the disease [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par20">Marker rs7852878, harbored in <italic>ASTN2</italic>, was also found to delay ADAOO in individuals with AD carrying the E280A mutation. ASTN2 is an integral membrane protein that participates in glial-guided neuronal migrations and is largely expressed within the hippocampus [<xref ref-type="bibr" rid="CR59">59</xref>]. Genomic variants in genes engaged in neuronal migration processes have been linked to several neurocognitive and psychiatric disorders. For instance, genes casually linked to schizophrenia such as <italic>Disrupted in schizophrenia-1</italic> (<italic>DISC1</italic>), <italic>Reelin, neuroregulin</italic> (<italic>NRG</italic>), and its receptor, <italic>ERBB4</italic>, control neuronal migration during brain development [<xref ref-type="bibr" rid="CR60">60</xref>]. Likewise, genes linked to ADHD (<italic>LPHN3</italic>) [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>], autism (<italic>YWHAZ</italic>) [<xref ref-type="bibr" rid="CR63">63</xref>], and depressive behavior (<italic>BDNF</italic>) [<xref ref-type="bibr" rid="CR64">64</xref>] also control neuronal fate within different brain regions. Interestingly, SNPs within <italic>ASTN2</italic> have been associated with cognitive decline and reduced hippocampal volume [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and several psychiatric conditions such as schizophrenia [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>], ADHD [<xref ref-type="bibr" rid="CR69">69</xref>], and bipolar disorder [<xref ref-type="bibr" rid="CR68">68</xref>]. More recently, genetic variants within <italic>ASTN2</italic> have been associated with ADAOO in late-onset AD [<xref ref-type="bibr" rid="CR70">70</xref>].</p><p id="Par21">We found that marker rs16914781 within <italic>SNTG1</italic> delays ADAOO by ~&#8201;3.2&#160;years in individuals carrying the <italic>PSEN1</italic> E280A mutation (Table <xref rid="Tab1" ref-type="table">1</xref>). SNTG1 belongs to the syntrophin family; it is an adapter protein that participates in the subcellular organization of several proteins. It also mediates gamma-enolase trafficking to the plasma membrane and is involved in neurotrophic signaling [<xref ref-type="bibr" rid="CR71">71</xref>]. SNTG1 is expressed exclusively in neurons, including Purkinje cells, hippocampal pyramidal cells, and in multiple cortical regions, where it could be playing important roles in the pathophysiology of AD and other neurodegenerative/neuropsychiatric conditions [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. <italic>SNTG1</italic> has been reported as a highly penetrant recessive locus in schizophrenia [<xref ref-type="bibr" rid="CR72">72</xref>], and as AOO modifier gene in AD [<xref ref-type="bibr" rid="CR7">7</xref>]. More recently, a circular RNA hotspot involving <italic>SNTG1</italic> has recently been identified in multiple system atrophy (MSA) [<xref ref-type="bibr" rid="CR73">73</xref>], a neurodegenerative disorder causing parkinsonism, cerebellar ataxia, and autonomic, urogenital, and pyramidal dysfunction in various combinations. Previously, a case report displayed an association of MSA and AD [<xref ref-type="bibr" rid="CR74">74</xref>]. <italic>SNTG1</italic> has also been implicated in obstructive sleep apnea [<xref ref-type="bibr" rid="CR75">75</xref>], a condition that is highly prevalent in patients with Alzheimer&#8217;s disease [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par22">To the best of our knowledge, we are the first to demonstrate a significant association between variants within <italic>ASTN2</italic> and <italic>SNTG1</italic>, and ADAOO in individuals with familial AD caused by a fully penetrant mutation. Our study suggests that the genetic variants described here exert a protective effect by delaying ADAOO up to ~&#8201;3.7&#160;years (Table <xref rid="Tab1" ref-type="table">1</xref>); this value increases to ~&#8201;11&#160;years when the <italic>APOE*E2</italic> allele is present (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>a). Future studies need to be performed to address the underlying action mechanism describing the interaction between <italic>ASTN2</italic> and <italic>PSEN1</italic>, and between <italic>STNG1</italic> and <italic>PSEN1</italic>.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec12"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12035_2018_1298_MOESM1_ESM.docx"><label>ESM 1</label><caption><p>(DOCX 331&#160;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>The authors express their highest appreciation to the patients and relatives enrolled in this study for more than 25&#160;years. This study was financed by a research grant from Australian National University (ANU) to MAB to launch his laboratory, and COLCIENCIAS and the University of Antioquia, grant 1115-408-20543. JIV and CAM were supported by grant R42100-2 from the John Curtin School of Medical Research, Canberra, ACT, Australia. MAB and CAM are currently supported by internal funds provided by the Universidad del Rosario. JIV is partially supported by research grant FOFICO 32101 PE0031 from Universidad del Norte. MLC-H is a doctoral student at Universidad del Norte, Barranquilla, Colombia. Some of this work is to be presented in partial fulfillment of the requirements for her PhD degree.</p></ack><notes notes-type="funding-information"><title>Role of Funding Source</title><p>The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the paper. JIV, CAM, and MAB have full access to all the data in the study and are responsible for submitting this work for publication. Data are available from the authors by request.</p></notes><notes notes-type="COI-statement"><title>Compliance with Ethical Standards</title><sec id="FPar1"><title>Conflict of Interest</title><p>The authors declare that they have no conflict of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brookmeyer</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Ziegler-Graham</surname><given-names>K</given-names></name><name><surname>Arrighi</surname><given-names>HM</given-names></name></person-group><article-title>Forecasting the global burden of Alzheimer&#8217;s disease</article-title><source>Alzheimers Dement</source><year>2007</year><volume>3</volume><issue>3</issue><fpage>186</fpage><lpage>191</lpage><?supplied-pmid 19595937?><pub-id pub-id-type="pmid">19595937</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group><article-title>Genetics of population isolates</article-title><source>Clin Genet</source><year>2002</year><volume>61</volume><issue>4</issue><fpage>233</fpage><lpage>247</lpage><?supplied-pmid 12030885?><pub-id pub-id-type="pmid">12030885</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Baena</surname><given-names>N</given-names></name><name><surname>Sepulveda-Falla</surname><given-names>D</given-names></name><name><surname>Lopera-Gomez</surname><given-names>CM</given-names></name><name><surname>Jaramillo-Elorza</surname><given-names>MC</given-names></name><name><surname>Moreno</surname><given-names>S</given-names></name><name><surname>Aguirre-Acevedo</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer&#8217;s disease: a retrospective cohort study</article-title><source>Lancet Neurol</source><year>2011</year><volume>10</volume><issue>3</issue><fpage>213</fpage><lpage>220</lpage><?supplied-pmid 21296022?><pub-id pub-id-type="pmid">21296022</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Ardilla</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Madrigal</surname><given-names>L</given-names></name><name><surname>Arango-Viana</surname><given-names>JC</given-names></name><name><surname>Lemere</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation</article-title><source>JAMA</source><year>1997</year><volume>277</volume><issue>10</issue><fpage>793</fpage><lpage>799</lpage><?supplied-pmid 9052708?><pub-id pub-id-type="pmid">9052708</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>ML</given-names></name><name><surname>Valenzuela</surname><given-names>CY</given-names></name><name><surname>Arcos-Burgos</surname><given-names>OM</given-names></name></person-group><article-title>Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia)</article-title><source>Gene Geogr</source><year>1996</year><volume>10</volume><issue>1</issue><fpage>11</fpage><lpage>17</lpage><?supplied-pmid 8913717?><pub-id pub-id-type="pmid">8913717</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono</surname><given-names>AC</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Arbelaez</surname><given-names>A</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Aguirre-Acevedo</surname><given-names>DC</given-names></name><name><surname>Richardson</surname><given-names>AM</given-names></name><name><surname>Easteal</surname><given-names>S</given-names></name><name><surname>Lidbury</surname><given-names>BA</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name></person-group><article-title>An 1H-MRS framework predicts the onset of Alzheimer&#8217;s disease symptoms in PSEN1 mutation carriers</article-title><source>Alzheimers Dement</source><year>2014</year><volume>10</volume><issue>5</issue><fpage>552</fpage><lpage>561</lpage><?supplied-pmid 24239247?><pub-id pub-id-type="pmid">24239247</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>JI</given-names></name><name><surname>Chandrasekharappa</surname><given-names>SC</given-names></name><name><surname>Henao</surname><given-names>E</given-names></name><name><surname>Martinez</surname><given-names>AF</given-names></name><name><surname>Harper</surname><given-names>U</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><etal/></person-group><article-title>Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer&#8217;s disease</article-title><source>Mol Psychiatry</source><year>2013</year><volume>18</volume><issue>5</issue><fpage>568</fpage><lpage>575</lpage><?supplied-pmid 22710270?><pub-id pub-id-type="pmid">22710270</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>JI</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Sepulveda-Falla</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>HR</given-names></name><name><surname>Johar</surname><given-names>AS</given-names></name><name><surname>Chuah</surname><given-names>A</given-names></name><etal/></person-group><article-title>APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer&#8217;s disease</article-title><source>Mol Psychiatry</source><year>2016</year><volume>21</volume><issue>7</issue><fpage>916</fpage><lpage>924</lpage><?supplied-pmid 26619808?><pub-id pub-id-type="pmid">26619808</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>JI</given-names></name><name><surname>Rivera</surname><given-names>D</given-names></name><name><surname>Mastronardi</surname><given-names>CA</given-names></name><name><surname>Patel</surname><given-names>HR</given-names></name><name><surname>Tobon</surname><given-names>C</given-names></name><name><surname>Villegas</surname><given-names>A</given-names></name><etal/></person-group><article-title>A mutation in DAOA modifies the age of onset in PSEN1 E280A Alzheimer&#8217;s disease</article-title><source>Neural Plast</source><year>2016</year><volume>2016</volume><fpage>9760314</fpage><?supplied-pmid 26949549?><pub-id pub-id-type="pmid">26949549</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>JI</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Patel</surname><given-names>HR</given-names></name><name><surname>Johar</surname><given-names>AS</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Rivera</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mutations modifying sporadic Alzheimer&#8217;s disease age of onset</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2016</year><volume>171</volume><issue>8</issue><fpage>1116</fpage><lpage>1130</lpage><?supplied-pmid 27573710?><pub-id pub-id-type="pmid">27573710</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Cheng</surname><given-names>R</given-names></name><name><surname>Vardarajan</surname><given-names>BN</given-names></name><name><surname>Lantigua</surname><given-names>RA</given-names></name><name><surname>Reyes-Dumeyer</surname><given-names>D</given-names></name><name><surname>Ortmann</surname><given-names>W</given-names></name><name><surname>Graham</surname><given-names>R</given-names></name><name><surname>Bhangale</surname><given-names>T</given-names></name><name><surname>Behrens</surname><given-names>T</given-names></name><name><surname>Medrano</surname><given-names>M</given-names></name><name><surname>Jimenez-Vel&#225;zquez</surname><given-names>I</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name></person-group><article-title>SORBS2, SH3RF3, and NPHP1 modify age at onset in carriers of the G206A mutation in PSEN1 with familial Alzheimer&#8217;s disease</article-title><source>Alzheimers Dement</source><year>2014</year><volume>10</volume><issue>4</issue><fpage>P632</fpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Cheng</surname><given-names>R</given-names></name><name><surname>Vardarajan</surname><given-names>B</given-names></name><name><surname>Lantigua</surname><given-names>R</given-names></name><name><surname>Reyes-Dumeyer</surname><given-names>D</given-names></name><name><surname>Ortmann</surname><given-names>W</given-names></name><name><surname>Graham</surname><given-names>RR</given-names></name><name><surname>Bhangale</surname><given-names>T</given-names></name><name><surname>Behrens</surname><given-names>TW</given-names></name><name><surname>Medrano</surname><given-names>M</given-names></name><name><surname>Jim&#233;nez-Vel&#225;zquez</surname><given-names>IZ</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name></person-group><article-title>Genetic modifiers of age at onset in carriers of the G206A mutation in PSEN1 with familial Alzheimer disease among Caribbean Hispanics</article-title><source>JAMA Neurol</source><year>2015</year><volume>72</volume><issue>9</issue><fpage>1043</fpage><lpage>1051</lpage><?supplied-pmid 26214276?><pub-id pub-id-type="pmid">26214276</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabris</surname><given-names>CF</given-names></name><name><surname>Hebert</surname><given-names>BM</given-names></name><name><surname>Benjamin</surname><given-names>DJ</given-names></name><name><surname>Beauchamp</surname><given-names>J</given-names></name><name><surname>Cesarini</surname><given-names>D</given-names></name><name><surname>van der Loos</surname><given-names>M</given-names></name><name><surname>Johannesson</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Atwood</surname><given-names>CS</given-names></name><name><surname>Freese</surname><given-names>J</given-names></name><name><surname>Hauser</surname><given-names>TS</given-names></name><name><surname>Hauser</surname><given-names>RM</given-names></name><name><surname>Christakis</surname><given-names>N</given-names></name><name><surname>Laibson</surname><given-names>D</given-names></name></person-group><article-title>Most reported genetic associations with general intelligence are probably false positives</article-title><source>Psychol Sci</source><year>2012</year><volume>23</volume><issue>11</issue><fpage>1314</fpage><lpage>1323</lpage><?supplied-pmid 23012269?><pub-id pub-id-type="pmid">23012269</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Tenesa</surname><given-names>A</given-names></name><name><surname>Payton</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Liewald</surname><given-names>D</given-names></name><name><surname>Ke</surname><given-names>X</given-names></name><name><surname>le Hellard</surname><given-names>S</given-names></name><name><surname>Christoforou</surname><given-names>A</given-names></name><name><surname>Luciano</surname><given-names>M</given-names></name><name><surname>McGhee</surname><given-names>K</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Gow</surname><given-names>AJ</given-names></name><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Redmond</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>HC</given-names></name><name><surname>Haggarty</surname><given-names>P</given-names></name><name><surname>Whalley</surname><given-names>LJ</given-names></name><name><surname>McNeill</surname><given-names>G</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Espeseth</surname><given-names>T</given-names></name><name><surname>Lundervold</surname><given-names>AJ</given-names></name><name><surname>Reinvang</surname><given-names>I</given-names></name><name><surname>Pickles</surname><given-names>A</given-names></name><name><surname>Steen</surname><given-names>VM</given-names></name><name><surname>Ollier</surname><given-names>W</given-names></name><name><surname>Porteous</surname><given-names>DJ</given-names></name><name><surname>Horan</surname><given-names>M</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Pendleton</surname><given-names>N</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name></person-group><article-title>Genome-wide association studies establish that human intelligence is highly heritable and polygenic</article-title><source>Mol Psychiatry</source><year>2011</year><volume>16</volume><issue>10</issue><fpage>996</fpage><lpage>1005</lpage><?supplied-pmid 21826061?><pub-id pub-id-type="pmid">21826061</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>JP</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><name><surname>Mellits</surname><given-names>ED</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name></person-group><article-title>The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer&#8217;s disease</article-title><source>Neurology</source><year>1989</year><volume>39</volume><issue>9</issue><fpage>1159</fpage><lpage>1165</lpage><?supplied-pmid 2771064?><pub-id pub-id-type="pmid">2771064</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleisher</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Quiroz</surname><given-names>YT</given-names></name><name><surname>Jakimovich</surname><given-names>LJ</given-names></name><name><surname>Gomez</surname><given-names>MG</given-names></name><name><surname>Langois</surname><given-names>CM</given-names></name><name><surname>Langbaum</surname><given-names>JBS</given-names></name><name><surname>Ayutyanont</surname><given-names>N</given-names></name><name><surname>Roontiva</surname><given-names>A</given-names></name><name><surname>Thiyyagura</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Mo</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Moreno</surname><given-names>S</given-names></name><name><surname>Acosta-Baena</surname><given-names>N</given-names></name><name><surname>Giraldo</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>G</given-names></name><name><surname>Reiman</surname><given-names>RA</given-names></name><name><surname>Huentelman</surname><given-names>MJ</given-names></name><name><surname>Kosik</surname><given-names>KS</given-names></name><name><surname>Tariot</surname><given-names>PN</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Reiman</surname><given-names>EM</given-names></name></person-group><article-title>Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study</article-title><source>Lancet Neurol</source><year>2012</year><volume>11</volume><issue>12</issue><fpage>1057</fpage><lpage>1065</lpage><?supplied-pmid 23137949?><pub-id pub-id-type="pmid">23137949</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiman</surname><given-names>EM</given-names></name><name><surname>Quiroz</surname><given-names>YT</given-names></name><name><surname>Fleisher</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Velez-Pardo</surname><given-names>C</given-names></name><name><surname>Jimenez-Del-Rio</surname><given-names>M</given-names></name><etal/></person-group><article-title>Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer&#8217;s disease in the presenilin 1 E280A kindred: a case-control study</article-title><source>Lancet Neurol</source><year>2012</year><volume>11</volume><issue>12</issue><fpage>1048</fpage><lpage>1056</lpage><?supplied-pmid 23137948?><pub-id pub-id-type="pmid">23137948</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiman</surname><given-names>EM</given-names></name><name><surname>Langbaum</surname><given-names>JB</given-names></name><name><surname>Fleisher</surname><given-names>AS</given-names></name><name><surname>Caselli</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Ayutyanont</surname><given-names>N</given-names></name><etal/></person-group><article-title>Alzheimer&#8217;s prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments</article-title><source>J Alzheimers Dis</source><year>2011</year><volume>26</volume><issue>Suppl 3</issue><fpage>321</fpage><lpage>329</lpage><?supplied-pmid 21971471?><pub-id pub-id-type="pmid">21971471</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Waring</surname><given-names>SC</given-names></name><name><surname>Ivnik</surname><given-names>RJ</given-names></name><name><surname>Tangalos</surname><given-names>EG</given-names></name><name><surname>Kokmen</surname><given-names>E</given-names></name></person-group><article-title>Mild cognitive impairment: clinical characterization and outcome</article-title><source>Arch Neurol</source><year>1999</year><volume>56</volume><issue>3</issue><fpage>303</fpage><lpage>308</lpage><?supplied-pmid 10190820?><pub-id pub-id-type="pmid">10190820</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Association AP. American Psychiatric Association: diagnostic and statistical manual of mental disorders. Fourth ed. Association AP, editor. Washington, D.C.2000.</mixed-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunderson</surname><given-names>KL</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Mendoza</surname><given-names>LG</given-names></name><name><surname>Chee</surname><given-names>MS</given-names></name></person-group><article-title>A genome-wide scalable SNP genotyping assay using microarray technology</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><issue>5</issue><fpage>549</fpage><lpage>554</lpage><?supplied-pmid 15838508?><pub-id pub-id-type="pmid">15838508</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>V</given-names></name><name><surname>Libiger</surname><given-names>O</given-names></name><name><surname>Torkamani</surname><given-names>A</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name></person-group><article-title>Statistical analysis strategies for association studies involving rare variants</article-title><source>Nat Rev Genet</source><year>2010</year><volume>11</volume><issue>11</issue><fpage>773</fpage><lpage>785</lpage><?supplied-pmid 20940738?><pub-id pub-id-type="pmid">20940738</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DJ</given-names></name><name><surname>Leal</surname><given-names>SM</given-names></name></person-group><article-title>A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions</article-title><source>PLoS Genet</source><year>2010</year><volume>6</volume><issue>10</issue><fpage>e1001156</fpage><?supplied-pmid 20976247?><pub-id pub-id-type="pmid">20976247</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DJ</given-names></name><name><surname>Leal</surname><given-names>SM</given-names></name></person-group><article-title>Replication strategies for rare variant complex trait association studies via next-generation sequencing</article-title><source>Am J Hum Genet</source><year>2010</year><volume>87</volume><issue>6</issue><fpage>790</fpage><lpage>801</lpage><?supplied-pmid 21129725?><pub-id pub-id-type="pmid">21129725</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura</surname><given-names>V</given-names></name><name><surname>Vilhjalmsson</surname><given-names>BJ</given-names></name><name><surname>Platt</surname><given-names>A</given-names></name><name><surname>Korte</surname><given-names>A</given-names></name><name><surname>Seren</surname><given-names>U</given-names></name><name><surname>Long</surname><given-names>Q</given-names></name><etal/></person-group><article-title>An efficient multi-locus mixed-model approach for genome-wide association studies in structured populations</article-title><source>Nat Genet</source><year>2012</year><volume>44</volume><issue>7</issue><fpage>825</fpage><lpage>830</lpage><?supplied-pmid 22706313?><pub-id pub-id-type="pmid">22706313</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>J R Stat Soc Ser B Methodol</source><year>1995</year><volume>57</volume><issue>1</issue><fpage>289</fpage><lpage>300</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#233;lez</surname><given-names>JI</given-names></name><name><surname>Correa</surname><given-names>JC</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name></person-group><article-title>A new method for detecting significant p-values with applications to genetic data</article-title><source>Revista Colombiana de Estadistica</source><year>2014</year><volume>37</volume><issue>1</issue><fpage>67</fpage><lpage>76</lpage></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>MT</given-names></name><name><surname>Velez</surname><given-names>JI</given-names></name><name><surname>Bustamante</surname><given-names>ML</given-names></name><name><surname>Balog</surname><given-names>JZ</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group><article-title>A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome</article-title><source>Transl Psychiatry</source><year>2011</year><volume>1</volume><fpage>e17</fpage><?supplied-pmid 22832519?><pub-id pub-id-type="pmid">22832519</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>HJ</given-names></name></person-group><article-title>Epistasis: what it means, what it doesn&#8217;t mean, and statistical methods to detect it in humans</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><issue>20</issue><fpage>2463</fpage><lpage>2468</lpage><?supplied-pmid 12351582?><pub-id pub-id-type="pmid">12351582</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Hill</surname><given-names>NJ</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name></person-group><article-title>Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes</article-title><source>Genetics</source><year>2001</year><volume>158</volume><issue>1</issue><fpage>357</fpage><lpage>367</lpage><?supplied-pmid 11333244?><pub-id pub-id-type="pmid">11333244</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>B</given-names></name></person-group><article-title>Bootstrap methods: another look at the Jacknife</article-title><source>Ann Stat</source><year>1979</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>26</lpage></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>B</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><article-title>Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy</article-title><source>Stat Sci</source><year>1986</year><volume>1</volume><issue>1</issue><fpage>54</fpage><lpage>77</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benaglia</surname><given-names>T</given-names></name><name><surname>Chauveau</surname><given-names>D</given-names></name><name><surname>Hunter</surname><given-names>DR</given-names></name><name><surname>Young</surname><given-names>D</given-names></name></person-group><article-title>Mixtools: an R package for analyzing finite mixture models</article-title><source>J Stat Softw</source><year>2009</year><volume>32</volume><issue>6</issue><fpage>1</fpage><lpage>29</lpage></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018.</mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lendon</surname><given-names>CL</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Behrens</surname><given-names>IM</given-names></name><name><surname>Kosik</surname><given-names>KS</given-names></name><name><surname>Madrigal</surname><given-names>L</given-names></name><name><surname>Norton</surname><given-names>J</given-names></name><name><surname>Neuman</surname><given-names>R</given-names></name><name><surname>Myers</surname><given-names>A</given-names></name><name><surname>Busfield</surname><given-names>F</given-names></name><name><surname>Wragg</surname><given-names>M</given-names></name><name><surname>Arcos</surname><given-names>M</given-names></name><name><surname>Viana</surname><given-names>JCA</given-names></name><name><surname>Ossa</surname><given-names>J</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Goate</surname><given-names>AM</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name></person-group><article-title>E280A PS-1 mutation causes Alzheimer&#8217;s disease but age of onset is not modified by ApoE alleles</article-title><source>Hum Mutat</source><year>1997</year><volume>10</volume><issue>3</issue><fpage>186</fpage><lpage>195</lpage><?supplied-pmid 9298817?><pub-id pub-id-type="pmid">9298817</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastor</surname><given-names>P</given-names></name><name><surname>Roe</surname><given-names>CM</given-names></name><name><surname>Villegas</surname><given-names>A</given-names></name><name><surname>Bedoya</surname><given-names>G</given-names></name><name><surname>Chakraverty</surname><given-names>S</given-names></name><name><surname>Garcia</surname><given-names>G</given-names></name><etal/></person-group><article-title>Apolipoprotein Eepsilon4 modifies Alzheimer&#8217;s disease onset in an E280A PS1 kindred</article-title><source>Ann Neurol</source><year>2003</year><volume>54</volume><issue>2</issue><fpage>163</fpage><lpage>169</lpage><?supplied-pmid 12891668?><pub-id pub-id-type="pmid">12891668</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>EH</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Risch</surname><given-names>NJ</given-names></name><name><surname>Strittmatter</surname><given-names>WJ</given-names></name><name><surname>Schmechel</surname><given-names>DE</given-names></name><name><surname>Gaskell</surname><given-names>PC</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease</article-title><source>Nat Genet</source><year>1994</year><volume>7</volume><issue>2</issue><fpage>180</fpage><lpage>184</lpage><?supplied-pmid 7920638?><pub-id pub-id-type="pmid">7920638</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlau</surname><given-names>DJ</given-names></name><name><surname>Corrada</surname><given-names>MM</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Kawas</surname><given-names>CH</given-names></name></person-group><article-title>APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old</article-title><source>Neurology</source><year>2009</year><volume>72</volume><issue>9</issue><fpage>829</fpage><lpage>834</lpage><?supplied-pmid 19255410?><pub-id pub-id-type="pmid">19255410</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdile</surname><given-names>G</given-names></name><name><surname>Fuller</surname><given-names>S</given-names></name><name><surname>Atwood</surname><given-names>CS</given-names></name><name><surname>Laws</surname><given-names>SM</given-names></name><name><surname>Gandy</surname><given-names>SE</given-names></name><name><surname>Martins</surname><given-names>RN</given-names></name></person-group><article-title>The role of beta amyloid in Alzheimer&#8217;s disease: still a cause of everything or the only one who got caught?</article-title><source>Pharmacol Res</source><year>2004</year><volume>50</volume><issue>4</issue><fpage>397</fpage><lpage>409</lpage><?supplied-pmid 15304237?><pub-id pub-id-type="pmid">15304237</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brier</surname><given-names>Matthew R.</given-names></name><name><surname>Gordon</surname><given-names>Brian</given-names></name><name><surname>Friedrichsen</surname><given-names>Karl</given-names></name><name><surname>McCarthy</surname><given-names>John</given-names></name><name><surname>Stern</surname><given-names>Ari</given-names></name><name><surname>Christensen</surname><given-names>Jon</given-names></name><name><surname>Owen</surname><given-names>Christopher</given-names></name><name><surname>Aldea</surname><given-names>Patricia</given-names></name><name><surname>Su</surname><given-names>Yi</given-names></name><name><surname>Hassenstab</surname><given-names>Jason</given-names></name><name><surname>Cairns</surname><given-names>Nigel J.</given-names></name><name><surname>Holtzman</surname><given-names>David M.</given-names></name><name><surname>Fagan</surname><given-names>Anne M.</given-names></name><name><surname>Morris</surname><given-names>John C.</given-names></name><name><surname>Benzinger</surname><given-names>Tammie L. S.</given-names></name><name><surname>Ances</surname><given-names>Beau M.</given-names></name></person-group><article-title>Tau and A&#946; imaging, CSF measures, and cognition in Alzheimer&#8217;s disease</article-title><source>Science Translational Medicine</source><year>2016</year><volume>8</volume><issue>338</issue><fpage>338ra66</fpage><lpage>338ra66</lpage><?supplied-pmid 27169802?><pub-id pub-id-type="pmid">27169802</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HG</given-names></name><name><surname>Casadesus</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Takeda</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name></person-group><article-title>Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1019</volume><fpage>1</fpage><lpage>4</lpage><?supplied-pmid 15246983?><pub-id pub-id-type="pmid">15246983</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fjell</surname><given-names>AM</given-names></name></person-group><article-title>McEvoy L, Holland D, Dale AM, Walhovd KB, Alzheimer&#8217;s disease neuroimaging I. What is normal in normal aging? Effects of aging, amyloid and Alzheimer&#8217;s disease on the cerebral cortex and the hippocampus</article-title><source>Prog Neurobiol</source><year>2014</year><volume>117</volume><fpage>20</fpage><lpage>40</lpage><?supplied-pmid 24548606?><pub-id pub-id-type="pmid">24548606</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>RJ</given-names></name><name><surname>Xiong</surname><given-names>C</given-names></name><name><surname>Benzinger</surname><given-names>TLS</given-names></name><name><surname>Fagan</surname><given-names>AM</given-names></name><name><surname>Goate</surname><given-names>A</given-names></name><name><surname>Fox</surname><given-names>NC</given-names></name><name><surname>Marcus</surname><given-names>DS</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Blazey</surname><given-names>TM</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name><name><surname>Santacruz</surname><given-names>A</given-names></name><name><surname>Buckles</surname><given-names>V</given-names></name><name><surname>Oliver</surname><given-names>A</given-names></name><name><surname>Moulder</surname><given-names>K</given-names></name><name><surname>Aisen</surname><given-names>PS</given-names></name><name><surname>Ghetti</surname><given-names>B</given-names></name><name><surname>Klunk</surname><given-names>WE</given-names></name><name><surname>McDade</surname><given-names>E</given-names></name><name><surname>Martins</surname><given-names>RN</given-names></name><name><surname>Masters</surname><given-names>CL</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><name><surname>Ringman</surname><given-names>JM</given-names></name><name><surname>Rossor</surname><given-names>MN</given-names></name><name><surname>Schofield</surname><given-names>PR</given-names></name><name><surname>Sperling</surname><given-names>RA</given-names></name><name><surname>Salloway</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><collab>Dominantly Inherited Alzheimer Network</collab></person-group><article-title>Clinical and biomarker changes in dominantly inherited Alzheimer&#8217;s disease</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><issue>9</issue><fpage>795</fpage><lpage>804</lpage><?supplied-pmid 22784036?><pub-id pub-id-type="pmid">22784036</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleisher</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Quiroz</surname><given-names>YT</given-names></name><name><surname>Jakimovich</surname><given-names>LJ</given-names></name><name><surname>Gomez</surname><given-names>MG</given-names></name><name><surname>Langois</surname><given-names>CM</given-names></name><name><surname>Langbaum</surname><given-names>JBS</given-names></name><name><surname>Ayutyanont</surname><given-names>N</given-names></name><name><surname>Roontiva</surname><given-names>A</given-names></name><name><surname>Thiyyagura</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Mo</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Moreno</surname><given-names>S</given-names></name><name><surname>Acosta-Baena</surname><given-names>N</given-names></name><name><surname>Giraldo</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>G</given-names></name><name><surname>Reiman</surname><given-names>RA</given-names></name><name><surname>Huentelman</surname><given-names>MJ</given-names></name><name><surname>Kosik</surname><given-names>KS</given-names></name><name><surname>Tariot</surname><given-names>PN</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Reiman</surname><given-names>EM</given-names></name></person-group><article-title>Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer&#8217;s disease kindred: a cross-sectional study</article-title><source>Lancet Neurol</source><year>2012</year><volume>11</volume><issue>12</issue><fpage>1057</fpage><lpage>1065</lpage><?supplied-pmid 23137949?><pub-id pub-id-type="pmid">23137949</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerreiro</surname><given-names>RJ</given-names></name><name><surname>Gustafson</surname><given-names>DR</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name></person-group><article-title>The genetic architecture of Alzheimer&#8217;s disease: beyond APP, PSENs and APOE</article-title><source>Neurobiol Aging</source><year>2012</year><volume>33</volume><issue>3</issue><fpage>437</fpage><lpage>456</lpage><?supplied-pmid 20594621?><pub-id pub-id-type="pmid">20594621</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>WD</given-names></name><name><surname>Wang</surname><given-names>YD</given-names></name></person-group><article-title>beta-amyloid: the key peptide in the pathogenesis of Alzheimer&#8217;s disease</article-title><source>Front Pharmacol</source><year>2015</year><volume>6</volume><fpage>221</fpage><?supplied-pmid 26483691?><pub-id pub-id-type="pmid">26483691</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemere</surname><given-names>CA</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Kosik</surname><given-names>KS</given-names></name><name><surname>Lendon</surname><given-names>CL</given-names></name><name><surname>Ossa</surname><given-names>J</given-names></name><name><surname>Saido</surname><given-names>TC</given-names></name><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Madrigal</surname><given-names>L</given-names></name><name><surname>Hincapie</surname><given-names>L</given-names></name><name><surname>Arango L.</surname><given-names>JC</given-names></name><name><surname>Anthony</surname><given-names>DC</given-names></name><name><surname>Koo</surname><given-names>EH</given-names></name><name><surname>Goate</surname><given-names>AM</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name><name><surname>Arango V.</surname><given-names>JC</given-names></name></person-group><article-title>The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><issue>10</issue><fpage>1146</fpage><lpage>1150</lpage><?supplied-pmid 8837617?><pub-id pub-id-type="pmid">8837617</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><article-title>Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior</article-title><source>Behav Brain Res</source><year>2008</year><volume>192</volume><issue>1</issue><fpage>106</fpage><lpage>113</lpage><?supplied-pmid 18359102?><pub-id pub-id-type="pmid">18359102</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>NR</given-names></name><name><surname>Ajit</surname><given-names>D</given-names></name><name><surname>Udan</surname><given-names>ML</given-names></name><name><surname>Nichols</surname><given-names>MR</given-names></name></person-group><article-title>Oligomeric amyloid-beta(1-42) induces THP-1 human monocyte adhesion and maturation</article-title><source>Brain Res</source><year>2009</year><volume>1254</volume><fpage>109</fpage><lpage>119</lpage><?supplied-pmid 19101527?><pub-id pub-id-type="pmid">19101527</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinamarca</surname><given-names>MC</given-names></name><name><surname>Rios</surname><given-names>JA</given-names></name><name><surname>Inestrosa</surname><given-names>NC</given-names></name></person-group><article-title>Postsynaptic receptors for amyloid-beta oligomers as mediators of neuronal damage in Alzheimer&#8217;s disease</article-title><source>Front Physiol</source><year>2012</year><volume>3</volume><fpage>464</fpage><?supplied-pmid 23267328?><pub-id pub-id-type="pmid">23267328</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>D</given-names></name><name><surname>Lue</surname><given-names>LF</given-names></name><name><surname>Paul</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Sabbagh</surname><given-names>MN</given-names></name></person-group><article-title>Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer&#8217;s disease</article-title><source>Expert Opin Investig Drugs</source><year>2015</year><volume>24</volume><issue>3</issue><fpage>393</fpage><lpage>399</lpage><?supplied-pmid 25586103?><pub-id pub-id-type="pmid">25586103</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>W</given-names></name><name><surname>Hanger</surname><given-names>DP</given-names></name><name><surname>Miller</surname><given-names>CC</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name></person-group><article-title>The importance of tau phosphorylation for neurodegenerative diseases</article-title><source>Front Neurol</source><year>2013</year><volume>4</volume><fpage>83</fpage><?supplied-pmid 23847585?><pub-id pub-id-type="pmid">23847585</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zempel</surname><given-names>H</given-names></name><name><surname>Thies</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>E</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><article-title>Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><issue>36</issue><fpage>11938</fpage><lpage>11950</lpage><?supplied-pmid 20826658?><pub-id pub-id-type="pmid">20826658</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>GS</given-names></name></person-group><article-title>Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis</article-title><source>JAMA Neurol</source><year>2014</year><volume>71</volume><issue>4</issue><fpage>505</fpage><lpage>508</lpage><?supplied-pmid 24493463?><pub-id pub-id-type="pmid">24493463</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amar</surname><given-names>F</given-names></name><name><surname>Sherman</surname><given-names>MA</given-names></name><name><surname>Rush</surname><given-names>T</given-names></name><name><surname>Larson</surname><given-names>M</given-names></name><name><surname>Boyle</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Amyloid-&#946; oligomer A&#946;*56 induces specific alterations of tau phosphorylation and neuronal signaling</article-title><source>Sci Signal</source><year>2017</year><volume>10</volume><issue>478</issue><fpage>eaal2021</fpage><?supplied-pmid 28487416?><pub-id pub-id-type="pmid">28487416</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suri</surname><given-names>S</given-names></name><name><surname>Heise</surname><given-names>V</given-names></name><name><surname>Trachtenberg</surname><given-names>AJ</given-names></name><name><surname>Mackay</surname><given-names>CE</given-names></name></person-group><article-title>The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2</article-title><source>Neurosci Biobehav Rev</source><year>2013</year><volume>37</volume><issue>10 Pt 2</issue><fpage>2878</fpage><lpage>2886</lpage><?supplied-pmid 24183852?><pub-id pub-id-type="pmid">24183852</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalmers</surname><given-names>K</given-names></name><name><surname>Wilcock</surname><given-names>GK</given-names></name><name><surname>Love</surname><given-names>S</given-names></name></person-group><article-title>APOE epsilon 4 influences the pathological phenotype of Alzheimer&#8217;s disease by favouring cerebrovascular over parenchymal accumulation of A beta protein</article-title><source>Neuropathol Appl Neurobiol</source><year>2003</year><volume>29</volume><issue>3</issue><fpage>231</fpage><lpage>238</lpage><?supplied-pmid 12787320?><pub-id pub-id-type="pmid">12787320</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanekiyo</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Bu</surname><given-names>G</given-names></name></person-group><article-title>ApoE and Abeta in Alzheimer&#8217;s disease: accidental encounters or partners?</article-title><source>Neuron</source><year>2014</year><volume>81</volume><issue>4</issue><fpage>740</fpage><lpage>754</lpage><?supplied-pmid 24559670?><pub-id pub-id-type="pmid">24559670</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukk</surname><given-names>M</given-names></name><name><surname>Kapushesky</surname><given-names>M</given-names></name><name><surname>Nikkila</surname><given-names>J</given-names></name><name><surname>Parkinson</surname><given-names>H</given-names></name><name><surname>Goncalves</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><etal/></person-group><article-title>A global map of human gene expression</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><issue>4</issue><fpage>322</fpage><lpage>324</lpage><?supplied-pmid 20379172?><pub-id pub-id-type="pmid">20379172</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>A</given-names></name><name><surname>Kubo</surname><given-names>K</given-names></name><name><surname>Tomoda</surname><given-names>T</given-names></name><name><surname>Takaki</surname><given-names>M</given-names></name><name><surname>Youn</surname><given-names>R</given-names></name><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Sawamura</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>U</given-names></name><name><surname>Kudo</surname><given-names>C</given-names></name><name><surname>Okawa</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Hatten</surname><given-names>ME</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name></person-group><article-title>A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development</article-title><source>Nat Cell Biol</source><year>2005</year><volume>7</volume><issue>12</issue><fpage>1167</fpage><lpage>1178</lpage><?supplied-pmid 16299498?><pub-id pub-id-type="pmid">16299498</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Acosta</surname><given-names>MT</given-names></name><name><surname>Shively</surname><given-names>S</given-names></name><name><surname>Stanescu</surname><given-names>H</given-names></name><name><surname>Wallis</surname><given-names>D</given-names></name><name><surname>Domen&#233;</surname><given-names>S</given-names></name><name><surname>V&#233;lez</surname><given-names>JI</given-names></name><name><surname>Karkera</surname><given-names>JD</given-names></name><name><surname>Balog</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>K</given-names></name><name><surname>Kleta</surname><given-names>R</given-names></name><name><surname>Gahl</surname><given-names>WA</given-names></name><name><surname>Roessler</surname><given-names>E</given-names></name><name><surname>Long</surname><given-names>R</given-names></name><name><surname>Lie</surname><given-names>J</given-names></name><name><surname>Pineda</surname><given-names>D</given-names></name><name><surname>Londo&#241;o</surname><given-names>AC</given-names></name><name><surname>Palacio</surname><given-names>JD</given-names></name><name><surname>Arbelaez</surname><given-names>A</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Elia</surname><given-names>J</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Knappskog</surname><given-names>PM</given-names></name><name><surname>Haavik</surname><given-names>J</given-names></name><name><surname>Ribases</surname><given-names>M</given-names></name><name><surname>Cormand</surname><given-names>B</given-names></name><name><surname>Bayes</surname><given-names>M</given-names></name><name><surname>Casas</surname><given-names>M</given-names></name><name><surname>Ramos-Quiroga</surname><given-names>JA</given-names></name><name><surname>Hervas</surname><given-names>A</given-names></name><name><surname>Maher</surname><given-names>BS</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Seitz</surname><given-names>C</given-names></name><name><surname>Freitag</surname><given-names>CM</given-names></name><name><surname>Palmason</surname><given-names>H</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Romanos</surname><given-names>M</given-names></name><name><surname>Walitza</surname><given-names>S</given-names></name><name><surname>Hemminger</surname><given-names>U</given-names></name><name><surname>Warnke</surname><given-names>A</given-names></name><name><surname>Romanos</surname><given-names>J</given-names></name><name><surname>Renner</surname><given-names>T</given-names></name><name><surname>Jacob</surname><given-names>C</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Swanson</surname><given-names>J</given-names></name><name><surname>Vortmeyer</surname><given-names>A</given-names></name><name><surname>Bailey-Wilson</surname><given-names>JE</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group><article-title>A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication</article-title><source>Mol Psychiatry</source><year>2010</year><volume>15</volume><issue>11</issue><fpage>1053</fpage><lpage>1066</lpage><?supplied-pmid 20157310?><pub-id pub-id-type="pmid">20157310</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Sullivan</surname><given-names>ML</given-names></name><name><surname>de Wit</surname><given-names>J</given-names></name><name><surname>Savas</surname><given-names>JN</given-names></name><name><surname>Comoletti</surname><given-names>D</given-names></name><name><surname>Otto-Hitt</surname><given-names>S</given-names></name><name><surname>Yates</surname><given-names>JR</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development</article-title><source>Neuron</source><year>2012</year><volume>73</volume><issue>5</issue><fpage>903</fpage><lpage>910</lpage><?supplied-pmid 22405201?><pub-id pub-id-type="pmid">22405201</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>C</given-names></name><name><surname>Torrico</surname><given-names>B</given-names></name><name><surname>Hervas</surname><given-names>A</given-names></name><name><surname>Valdes-Mas</surname><given-names>R</given-names></name><name><surname>Tristan-Noguero</surname><given-names>A</given-names></name><name><surname>Padillo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations</article-title><source>Mol Psychiatry</source><year>2014</year><volume>19</volume><issue>7</issue><fpage>784</fpage><lpage>790</lpage><?supplied-pmid 23999528?><pub-id pub-id-type="pmid">23999528</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BH</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group><article-title>The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment</article-title><source>Psychiatry Investig</source><year>2010</year><volume>7</volume><issue>4</issue><fpage>231</fpage><lpage>235</lpage><?supplied-pmid 21253405?><pub-id pub-id-type="pmid">21253405</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>van der Lijn</surname><given-names>F</given-names></name><name><surname>Crivello</surname><given-names>F</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Srikanth</surname><given-names>V</given-names></name><name><surname>Schuur</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Sigurdsson</surname><given-names>S</given-names></name><name><surname>Verhaaren</surname><given-names>BF</given-names></name><name><surname>DeStefano</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>JC</given-names></name><name><surname>Jack CR Jr</surname></name><name><surname>Struchalin</surname><given-names>M</given-names></name><name><surname>Stankovich</surname><given-names>J</given-names></name><name><surname>Ibrahim-Verbaas</surname><given-names>CA</given-names></name><name><surname>Fleischman</surname><given-names>D</given-names></name><name><surname>Zijdenbos</surname><given-names>A</given-names></name><name><surname>den Heijer</surname><given-names>T</given-names></name><name><surname>Mazoyer</surname><given-names>B</given-names></name><name><surname>Coker</surname><given-names>LH</given-names></name><name><surname>Enzinger</surname><given-names>C</given-names></name><name><surname>Danoy</surname><given-names>P</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Arfanakis</surname><given-names>K</given-names></name><name><surname>van Buchem</surname><given-names>M</given-names></name><name><surname>de Bruijn</surname><given-names>RF</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Cavalieri</surname><given-names>M</given-names></name><name><surname>Thomson</surname><given-names>R</given-names></name><name><surname>Niessen</surname><given-names>WJ</given-names></name><name><surname>Chibnik</surname><given-names>LB</given-names></name><name><surname>Gislason</surname><given-names>GK</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Pikula</surname><given-names>A</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Freeman</surname><given-names>KB</given-names></name><name><surname>Phan</surname><given-names>TG</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Vasquez</surname><given-names>AA</given-names></name><name><surname>Hibar</surname><given-names>DP</given-names></name><name><surname>Wright</surname><given-names>MJ</given-names></name><name><surname>Franke</surname><given-names>B</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><collab>Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium</collab><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Au</surname><given-names>R</given-names></name><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Beare</surname><given-names>RJ</given-names></name><name><surname>van Swieten</surname><given-names>J</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Chouraki</surname><given-names>V</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>de Jager</surname><given-names>PL</given-names></name><name><surname>Becker</surname><given-names>JT</given-names></name><name><surname>Vernooij</surname><given-names>MW</given-names></name><name><surname>Knopman</surname><given-names>D</given-names></name><name><surname>Fazekas</surname><given-names>F</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>van der Lugt</surname><given-names>A</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Longstreth WT Jr</surname></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>van Duijn</surname><given-names>C</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><collab>Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium</collab></person-group><article-title>Common variants at 12q14 and 12q24 are associated with hippocampal volume</article-title><source>Nat Genet</source><year>2012</year><volume>44</volume><issue>5</issue><fpage>545</fpage><lpage>551</lpage><?supplied-pmid 22504421?><pub-id pub-id-type="pmid">22504421</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibar</surname><given-names>DP</given-names></name><name><surname>Adams</surname><given-names>HHH</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name><name><surname>Chauhan</surname><given-names>G</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Hofer</surname><given-names>E</given-names></name><name><surname>Renteria</surname><given-names>ME</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Arias-Vasquez</surname><given-names>A</given-names></name><name><surname>Ikram</surname><given-names>MK</given-names></name><name><surname>Desrivi&#232;res</surname><given-names>S</given-names></name><name><surname>Vernooij</surname><given-names>MW</given-names></name><name><surname>Abramovic</surname><given-names>L</given-names></name><name><surname>Alhusaini</surname><given-names>S</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Arfanakis</surname><given-names>K</given-names></name><name><surname>Aribisala</surname><given-names>BS</given-names></name><name><surname>Armstrong</surname><given-names>NJ</given-names></name><name><surname>Athanasiu</surname><given-names>L</given-names></name><name><surname>Axelsson</surname><given-names>T</given-names></name><name><surname>Beecham</surname><given-names>AH</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>M</given-names></name><name><surname>Blanton</surname><given-names>SH</given-names></name><name><surname>Bohlken</surname><given-names>MM</given-names></name><name><surname>Boks</surname><given-names>MP</given-names></name><name><surname>Bralten</surname><given-names>J</given-names></name><name><surname>Brickman</surname><given-names>AM</given-names></name><name><surname>Carmichael</surname><given-names>O</given-names></name><name><surname>Chakravarty</surname><given-names>MM</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Ching</surname><given-names>CRK</given-names></name><name><surname>Chouraki</surname><given-names>V</given-names></name><name><surname>Cuellar-Partida</surname><given-names>G</given-names></name><name><surname>Crivello</surname><given-names>F</given-names></name><name><surname>den Braber</surname><given-names>A</given-names></name><name><surname>Doan</surname><given-names>NT</given-names></name><name><surname>Ehrlich</surname><given-names>S</given-names></name><name><surname>Giddaluru</surname><given-names>S</given-names></name><name><surname>Goldman</surname><given-names>AL</given-names></name><name><surname>Gottesman</surname><given-names>RF</given-names></name><name><surname>Grimm</surname><given-names>O</given-names></name><name><surname>Griswold</surname><given-names>ME</given-names></name><name><surname>Guadalupe</surname><given-names>T</given-names></name><name><surname>Gutman</surname><given-names>BA</given-names></name><name><surname>Hass</surname><given-names>J</given-names></name><name><surname>Haukvik</surname><given-names>UK</given-names></name><name><surname>Hoehn</surname><given-names>D</given-names></name><name><surname>Holmes</surname><given-names>AJ</given-names></name><name><surname>Hoogman</surname><given-names>M</given-names></name><name><surname>Janowitz</surname><given-names>D</given-names></name><name><surname>Jia</surname><given-names>T</given-names></name><name><surname>J&#248;rgensen</surname><given-names>KN</given-names></name><name><surname>Karbalai</surname><given-names>N</given-names></name><name><surname>Kasperaviciute</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>Kraemer</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Liewald</surname><given-names>DCM</given-names></name><name><surname>Lopez</surname><given-names>LM</given-names></name><name><surname>Luciano</surname><given-names>M</given-names></name><name><surname>Macare</surname><given-names>C</given-names></name><name><surname>Marquand</surname><given-names>AF</given-names></name><name><surname>Matarin</surname><given-names>M</given-names></name><name><surname>Mather</surname><given-names>KA</given-names></name><name><surname>Mattheisen</surname><given-names>M</given-names></name><name><surname>McKay</surname><given-names>DR</given-names></name><name><surname>Milaneschi</surname><given-names>Y</given-names></name><name><surname>Mu&#241;oz Maniega</surname><given-names>S</given-names></name><name><surname>Nho</surname><given-names>K</given-names></name><name><surname>Nugent</surname><given-names>AC</given-names></name><name><surname>Nyquist</surname><given-names>P</given-names></name><name><surname>Loohuis</surname><given-names>LMO</given-names></name><name><surname>Oosterlaan</surname><given-names>J</given-names></name><name><surname>Papmeyer</surname><given-names>M</given-names></name><name><surname>Pirpamer</surname><given-names>L</given-names></name><name><surname>P&#252;tz</surname><given-names>B</given-names></name><name><surname>Ramasamy</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>JS</given-names></name><name><surname>Risacher</surname><given-names>SL</given-names></name><name><surname>Roiz-Santia&#241;ez</surname><given-names>R</given-names></name><name><surname>Rommelse</surname><given-names>N</given-names></name><name><surname>Ropele</surname><given-names>S</given-names></name><name><surname>Rose</surname><given-names>EJ</given-names></name><name><surname>Royle</surname><given-names>NA</given-names></name><name><surname>Rundek</surname><given-names>T</given-names></name><name><surname>S&#228;mann</surname><given-names>PG</given-names></name><name><surname>Saremi</surname><given-names>A</given-names></name><name><surname>Satizabal</surname><given-names>CL</given-names></name><name><surname>Schmaal</surname><given-names>L</given-names></name><name><surname>Schork</surname><given-names>AJ</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Shumskaya</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Sprooten</surname><given-names>E</given-names></name><name><surname>Strike</surname><given-names>LT</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Tordesillas-Gutierrez</surname><given-names>D</given-names></name><name><surname>Toro</surname><given-names>R</given-names></name><name><surname>Trabzuni</surname><given-names>D</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Vaidya</surname><given-names>D</given-names></name><name><surname>van der Grond</surname><given-names>J</given-names></name><name><surname>van der Lee</surname><given-names>SJ</given-names></name><name><surname>van der Meer</surname><given-names>D</given-names></name><name><surname>van Donkelaar</surname><given-names>MMJ</given-names></name><name><surname>van Eijk</surname><given-names>KR</given-names></name><name><surname>van Erp</surname><given-names>TGM</given-names></name><name><surname>van Rooij</surname><given-names>D</given-names></name><name><surname>Walton</surname><given-names>E</given-names></name><name><surname>Westlye</surname><given-names>LT</given-names></name><name><surname>Whelan</surname><given-names>CD</given-names></name><name><surname>Windham</surname><given-names>BG</given-names></name><name><surname>Winkler</surname><given-names>AM</given-names></name><name><surname>Wittfeld</surname><given-names>K</given-names></name><name><surname>Woldehawariat</surname><given-names>G</given-names></name><name><surname>Wolf</surname><given-names>C</given-names></name><name><surname>Wolfers</surname><given-names>T</given-names></name><name><surname>Yanek</surname><given-names>LR</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zijdenbos</surname><given-names>A</given-names></name><name><surname>Zwiers</surname><given-names>MP</given-names></name><name><surname>Agartz</surname><given-names>I</given-names></name><name><surname>Almasy</surname><given-names>L</given-names></name><name><surname>Ames</surname><given-names>D</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Arepalli</surname><given-names>S</given-names></name><name><surname>Assareh</surname><given-names>AA</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Bastin</surname><given-names>ME</given-names></name><name><surname>Becker</surname><given-names>DM</given-names></name><name><surname>Becker</surname><given-names>JT</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>van Bokhoven</surname><given-names>H</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><name><surname>Brouwer</surname><given-names>RM</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name><name><surname>Buckner</surname><given-names>RL</given-names></name><name><surname>Buitelaar</surname><given-names>JK</given-names></name><name><surname>Bulayeva</surname><given-names>KB</given-names></name><name><surname>Cahn</surname><given-names>W</given-names></name><name><surname>Calhoun</surname><given-names>VD</given-names></name><name><surname>Cannon</surname><given-names>DM</given-names></name><name><surname>Cavalleri</surname><given-names>GL</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name><name><surname>Cookson</surname><given-names>MR</given-names></name><name><surname>Corvin</surname><given-names>A</given-names></name><name><surname>Crespo-Facorro</surname><given-names>B</given-names></name><name><surname>Curran</surname><given-names>JE</given-names></name><name><surname>Czisch</surname><given-names>M</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name><name><surname>Davies</surname><given-names>GE</given-names></name><name><surname>de Craen</surname><given-names>AJM</given-names></name><name><surname>de Geus</surname><given-names>EJC</given-names></name><name><surname>de Jager</surname><given-names>PL</given-names></name><name><surname>de Zubicaray</surname><given-names>GI</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Delanty</surname><given-names>N</given-names></name><name><surname>Depondt</surname><given-names>C</given-names></name><name><surname>DeStefano</surname><given-names>A</given-names></name><name><surname>Dillman</surname><given-names>A</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Donohoe</surname><given-names>G</given-names></name><name><surname>Drevets</surname><given-names>WC</given-names></name><name><surname>Duggirala</surname><given-names>R</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>Enzinger</surname><given-names>C</given-names></name><name><surname>Erk</surname><given-names>S</given-names></name><name><surname>Espeseth</surname><given-names>T</given-names></name><name><surname>Fedko</surname><given-names>IO</given-names></name><name><surname>Fern&#225;ndez</surname><given-names>G</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Fleischman</surname><given-names>DA</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Foroud</surname><given-names>TM</given-names></name><name><surname>Fox</surname><given-names>PT</given-names></name><name><surname>Francks</surname><given-names>C</given-names></name><name><surname>Fukunaga</surname><given-names>M</given-names></name><name><surname>Gibbs</surname><given-names>JR</given-names></name><name><surname>Glahn</surname><given-names>DC</given-names></name><name><surname>Gollub</surname><given-names>RL</given-names></name><name><surname>G&#246;ring</surname><given-names>HHH</given-names></name><name><surname>Green</surname><given-names>RC</given-names></name><name><surname>Gruber</surname><given-names>O</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Guelfi</surname><given-names>S</given-names></name><name><surname>H&#229;berg</surname><given-names>AK</given-names></name><name><surname>Hansell</surname><given-names>NK</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Hashimoto</surname><given-names>R</given-names></name><name><surname>Hegenscheid</surname><given-names>K</given-names></name><name><surname>Heinz</surname><given-names>A</given-names></name><name><surname>le Hellard</surname><given-names>S</given-names></name><name><surname>Hernandez</surname><given-names>DG</given-names></name><name><surname>Heslenfeld</surname><given-names>DJ</given-names></name><name><surname>Ho</surname><given-names>BC</given-names></name><name><surname>Hoekstra</surname><given-names>PJ</given-names></name><name><surname>Hoffmann</surname><given-names>W</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Holsboer</surname><given-names>F</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Hosten</surname><given-names>N</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Huentelman</surname><given-names>M</given-names></name><name><surname>Pol</surname><given-names>HEH</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Jack Jr</surname><given-names>CR</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>J&#246;nsson</surname><given-names>EG</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Kanai</surname><given-names>R</given-names></name><name><surname>Kloszewska</surname><given-names>I</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Kochunov</surname><given-names>P</given-names></name><name><surname>Kwok</surname><given-names>JB</given-names></name><name><surname>Lawrie</surname><given-names>SM</given-names></name><name><surname>Lema&#238;tre</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Martinez</surname><given-names>O</given-names></name><name><surname>Martinot</surname><given-names>JL</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>McDonald</surname><given-names>C</given-names></name><name><surname>McIntosh</surname><given-names>AM</given-names></name><name><surname>McMahon</surname><given-names>FJ</given-names></name><name><surname>McMahon</surname><given-names>KL</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Mohnke</surname><given-names>S</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names></name><name><surname>M&#252;hleisen</surname><given-names>TW</given-names></name><name><surname>M&#252;ller-Myhsok</surname><given-names>B</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name><name><surname>Niessen</surname><given-names>WJ</given-names></name><name><surname>N&#246;then</surname><given-names>MM</given-names></name><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Ohi</surname><given-names>K</given-names></name><name><surname>Olvera</surname><given-names>RL</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>Pandolfo</surname><given-names>M</given-names></name><name><surname>Paus</surname><given-names>T</given-names></name><name><surname>Pausova</surname><given-names>Z</given-names></name><name><surname>Penninx</surname><given-names>BWJH</given-names></name><name><surname>Pike</surname><given-names>GB</given-names></name><name><surname>Potkin</surname><given-names>SG</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Reppermund</surname><given-names>S</given-names></name><name><surname>Rietschel</surname><given-names>M</given-names></name><name><surname>Roffman</surname><given-names>JL</given-names></name><name><surname>Romanczuk-Seiferth</surname><given-names>N</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Ryten</surname><given-names>M</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Sachdev</surname><given-names>PS</given-names></name><name><surname>Saykin</surname><given-names>AJ</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Schofield</surname><given-names>PR</given-names></name><name><surname>Sigursson</surname><given-names>S</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Sisodiya</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Steen</surname><given-names>VM</given-names></name><name><surname>Stott</surname><given-names>DJ</given-names></name><name><surname>Sussmann</surname><given-names>JE</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Toga</surname><given-names>AW</given-names></name><name><surname>Traynor</surname><given-names>BJ</given-names></name><name><surname>Troncoso</surname><given-names>J</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Hern&#225;ndez</surname><given-names>MCV</given-names></name><name><surname>van der Brug</surname><given-names>M</given-names></name><name><surname>van der Lugt</surname><given-names>A</given-names></name><name><surname>van der Wee</surname><given-names>NJA</given-names></name><name><surname>van Haren</surname><given-names>NEM</given-names></name><name><surname>van &#8217;t Ent</surname><given-names>D</given-names></name><name><surname>van Tol</surname><given-names>MJ</given-names></name><name><surname>Vardarajan</surname><given-names>BN</given-names></name><name><surname>Vellas</surname><given-names>B</given-names></name><name><surname>Veltman</surname><given-names>DJ</given-names></name><name><surname>V&#246;lzke</surname><given-names>H</given-names></name><name><surname>Walter</surname><given-names>H</given-names></name><name><surname>Wardlaw</surname><given-names>JM</given-names></name><name><surname>Wassink</surname><given-names>TH</given-names></name><name><surname>Weale</surname><given-names>ME</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Weiner</surname><given-names>MW</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Westman</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name><name><surname>Wright</surname><given-names>CB</given-names></name><name><surname>Zielke</surname><given-names>RH</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Wright</surname><given-names>MJ</given-names></name><name><surname>Longstreth</surname><given-names>WT</given-names></name><name><surname>Schumann</surname><given-names>G</given-names></name><name><surname>Grabe</surname><given-names>HJ</given-names></name><name><surname>Franke</surname><given-names>B</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name></person-group><article-title>Novel genetic loci associated with hippocampal volume</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>13624</fpage><?supplied-pmid 28098162?><pub-id pub-id-type="pmid">28098162</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrijenhoek</surname><given-names>T</given-names></name><name><surname>Buizer-Voskamp</surname><given-names>JE</given-names></name><name><surname>van der Stelt</surname><given-names>I</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>Genetic</surname><given-names>R</given-names></name><collab>Outcome in Psychosis C</collab><etal/></person-group><article-title>Recurrent CNVs disrupt three candidate genes in schizophrenia patients</article-title><source>Am J Hum Genet</source><year>2008</year><volume>83</volume><issue>4</issue><fpage>504</fpage><lpage>510</lpage><?supplied-pmid 18940311?><pub-id pub-id-type="pmid">18940311</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KS</given-names></name><name><surname>Liu</surname><given-names>XF</given-names></name><name><surname>Aragam</surname><given-names>N</given-names></name></person-group><article-title>A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder</article-title><source>Schizophr Res</source><year>2010</year><volume>124</volume><issue>1&#8211;3</issue><fpage>192</fpage><lpage>199</lpage><?supplied-pmid 20889312?><pub-id pub-id-type="pmid">20889312</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Timmesfeld</surname><given-names>N</given-names></name><name><surname>Renner</surname><given-names>TJ</given-names></name><name><surname>Halperin</surname><given-names>R</given-names></name><name><surname>Roser</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><etal/></person-group><article-title>Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies</article-title><source>J Neural Transm (Vienna)</source><year>2008</year><volume>115</volume><issue>11</issue><fpage>1573</fpage><lpage>1585</lpage><pub-id pub-id-type="pmid">18839057</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KS</given-names></name><name><surname>Tonarelli</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Zuo</surname><given-names>L</given-names></name><name><surname>Mao</surname><given-names>CX</given-names></name><name><surname>Rubin</surname><given-names>L</given-names></name><name><surname>Briones</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name></person-group><article-title>Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer&#8217;s disease</article-title><source>J Neural Transm (Vienna)</source><year>2015</year><volume>122</volume><issue>5</issue><fpage>701</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">25410587</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname><given-names>A</given-names></name><name><surname>Obermajer</surname><given-names>N</given-names></name><name><surname>Kos</surname><given-names>J</given-names></name></person-group><article-title>Gamma-1-syntrophin mediates trafficking of gamma-enolase towards the plasma membrane and enhances its neurotrophic activity</article-title><source>Neurosignals</source><year>2010</year><volume>18</volume><issue>4</issue><fpage>246</fpage><lpage>258</lpage><?supplied-pmid 21358174?><pub-id pub-id-type="pmid">21358174</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lencz</surname><given-names>T</given-names></name><name><surname>Lambert</surname><given-names>C</given-names></name><name><surname>DeRosse</surname><given-names>P</given-names></name><name><surname>Burdick</surname><given-names>KE</given-names></name><name><surname>Morgan</surname><given-names>TV</given-names></name><name><surname>Kane</surname><given-names>JM</given-names></name><name><surname>Kucherlapati</surname><given-names>R</given-names></name><name><surname>Malhotra</surname><given-names>AK</given-names></name></person-group><article-title>Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><issue>50</issue><fpage>19942</fpage><lpage>19947</lpage><?supplied-pmid 18077426?><pub-id pub-id-type="pmid">18077426</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BJ</given-names></name><name><surname>Mills</surname><given-names>JD</given-names></name><name><surname>Takenaka</surname><given-names>K</given-names></name><name><surname>Bliim</surname><given-names>N</given-names></name><name><surname>Halliday</surname><given-names>GM</given-names></name><name><surname>Janitz</surname><given-names>M</given-names></name></person-group><article-title>Characterization of circular RNAs landscape in multiple system atrophy brain</article-title><source>J Neurochem</source><year>2016</year><volume>139</volume><issue>3</issue><fpage>485</fpage><lpage>496</lpage><?supplied-pmid 27470294?><pub-id pub-id-type="pmid">27470294</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusina</surname><given-names>R</given-names></name><name><surname>Bourdain</surname><given-names>F</given-names></name><name><surname>Matej</surname><given-names>R</given-names></name></person-group><article-title>Multiple system atrophy and Alzheimer&#8217;s disease: a case report of a rare association of two neuro-degenerative disorders</article-title><source>Rev Neurol (Paris)</source><year>2007</year><volume>163</volume><issue>12</issue><fpage>1239</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">18355473</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Cade</surname><given-names>BE</given-names></name><name><surname>Gleason</surname><given-names>KJ</given-names></name><name><surname>Bjonnes</surname><given-names>AC</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Sofer</surname><given-names>T</given-names></name><name><surname>Conomos</surname><given-names>MP</given-names></name><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><name><surname>Arens</surname><given-names>R</given-names></name><name><surname>Azarbarzin</surname><given-names>A</given-names></name><name><surname>Bell</surname><given-names>GI</given-names></name><name><surname>Below</surname><given-names>JE</given-names></name><name><surname>Chun</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>DS</given-names></name><name><surname>Ewert</surname><given-names>R</given-names></name><name><surname>Frazier-Wood</surname><given-names>AC</given-names></name><name><surname>Gharib</surname><given-names>SA</given-names></name><name><surname>Haba-Rubio</surname><given-names>J</given-names></name><name><surname>Hagen</surname><given-names>EW</given-names></name><name><surname>Heinzer</surname><given-names>R</given-names></name><name><surname>Hillman</surname><given-names>DR</given-names></name><name><surname>Johnson</surname><given-names>WC</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Lane</surname><given-names>JM</given-names></name><name><surname>Larkin</surname><given-names>EK</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Loredo</surname><given-names>JS</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Papanicolaou</surname><given-names>GJ</given-names></name><name><surname>Penzel</surname><given-names>T</given-names></name><name><surname>Peppard</surname><given-names>PE</given-names></name><name><surname>Post</surname><given-names>WS</given-names></name><name><surname>Ramos</surname><given-names>AR</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Sands</surname><given-names>SA</given-names></name><name><surname>Shah</surname><given-names>NA</given-names></name><name><surname>Shin</surname><given-names>C</given-names></name><name><surname>Stone</surname><given-names>KL</given-names></name><name><surname>Stubbe</surname><given-names>B</given-names></name><name><surname>Sul</surname><given-names>JH</given-names></name><name><surname>Tafti</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thornton</surname><given-names>TA</given-names></name><name><surname>Tranah</surname><given-names>GJ</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Warby</surname><given-names>SC</given-names></name><name><surname>Wellman</surname><given-names>DA</given-names></name><name><surname>Zee</surname><given-names>PC</given-names></name><name><surname>Hanis</surname><given-names>CL</given-names></name><name><surname>Laurie</surname><given-names>CC</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Sunyaev</surname><given-names>SR</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name></person-group><article-title>Multiethnic meta-analysis identifies RAI1 as a possible obstructive sleep apnea-related quantitative trait locus in men</article-title><source>Am J Respir Cell Mol Biol</source><year>2018</year><volume>58</volume><issue>3</issue><fpage>391</fpage><lpage>401</lpage><?supplied-pmid 29077507?><pub-id pub-id-type="pmid">29077507</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emamian</surname><given-names>F</given-names></name><name><surname>Khazaie</surname><given-names>H</given-names></name><name><surname>Tahmasian</surname><given-names>M</given-names></name><name><surname>Leschziner</surname><given-names>GD</given-names></name><name><surname>Morrell</surname><given-names>MJ</given-names></name><name><surname>Hsiung</surname><given-names>GY</given-names></name><etal/></person-group><article-title>The association between obstructive sleep apnea and Alzheimer&#8217;s disease: a meta-analysis perspective</article-title><source>Front Aging Neurosci</source><year>2016</year><volume>8</volume><fpage>78</fpage><?supplied-pmid 27148046?><pub-id pub-id-type="pmid">27148046</pub-id></element-citation></ref></ref-list></back></article>